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Abstract 
 
Anaerobic bacteria cause serious life-threatening infections such as endocarditis, sepsis, 
intra abdominal, pleuro-pulmonary and central nervous systems infections. Most infections 
are polymicrobial and involve aerobes and anaerobes. Empiric therapy is generally based 
on the expected pathogens and the particular type of infection. Even when specimens are 
cultured and anaerobes identified, not all laboratories perform susceptibility testing. The 
clinician often relies on published surveillance data when selecting treatment regimens. 
Antimicrobial susceptibility of anaerobic bacteria is becoming increasingly unpredictable. 
Resistance can vary significantly and patterns differ geographically, and even within units 
of the same hospital. 
 
From June 2005 until February 2007, 180 consecutive anaerobes isolated from relevant, 
non- repetitive clinical specimens were tested routinely with the E test method for   
susceptibility to amoxicillin/ clavulanate (XL), clindamycin (Cm), metronidazole (Mz), 
penicillin (Pg), ertapenem (Etp), cefoxitin (Fx), ceftriaxone (Tx), chloramphenicol (Cl), 
and piperacillin/tazobactam (Ptc). The results were read after 48hr incubation in anaerobic 
conditions. Specimen distribution was as follows: abdominal fluid (3), abscess (7), 
abdominal abscess (4), aspirates (3), blood cultures (27), bone (3), breast (3), drainage 
fluid (2), empyema (1), fluids (36), other (4), placental (1), pleural fluid (2), pus (41), 
tissues (34), umbilicus (1) and unknown sites (8). 
 
Bacteroides fragilis was isolated from 81 (45%) clinically significant specimens, followed 
by Clostridium perfringens 23 (13%), Peptostreptococcus anaerobius 15 (8%) and 
Prevotella melaniniogenicus 15 (8%). B. fragilis demonstrated a 97.5% resistance to 
penicillin and 12.3% resistance to metronidazole. C. perfringens exhibited no resistance to 
penicillin and metronidazole while P. anaerobius had 40% resistance to penicillin and no 
resistance to metronidazole. P. melaninogenicus was resistant to penicillin in 60% and 
6.7% to metronidazole. Overall, chloramphenicol, piperacillin/tazobactam, ertapenem and 
amoxicillin/clavulanate demonstrated the highest activity to anaerobic isolates, 100%, 
99.4%, 97.2% and 96.7%, respectively. Among the 180 tested anaerobes a total of 8.9% 
resistance has been observed with metronidazole and 81.7% sensitivity with clindamycin.  
 
Periodic surveillance to monitor the susceptibility profile of the B. fragilis group and other 
anaerobic organisms is recommended to create empirical guidelines for appropriate use of 
antimicrobial agents. 
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Preface 
 
 
 
Antimicrobial susceptibilities of anaerobes are generally thought to be more predictable 
than those of other bacteria. However, the increasing resistance of anaerobes to some 
agents has been observed, making their susceptibility patterns less predictable. Although 
isolation and identification are neither practical nor readily available for the individual 
patient, knowledge of the susceptibility of anaerobic antibiotics at individual hospitals is 
important in the selection of empirical antimicrobial therapy. 
 
Variation in the susceptibility of anaerobes can be the result of differences in geographical 
distribution, site of infection, clonal population, as well as regional antimicrobial use. 
Various surveillance programs continue to monitor susceptibility to antimicrobial agents 
for common pathogens at local, regional, national, and global level. With increasing trends 
in antimicrobial resistance worldwide, it is essential to monitor emerging drug resistance at 
the local level to support clinical decisions, infection-control interventions, and 
antimicrobial resistance containment strategies. 
 
Therefore, surveillance of antimicrobial susceptibility pattern is needed to detect extent of 
resistance and to guide clinicians to use antibiotics appropriately.   
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Abbreviations used in text  
 
 
Abbreviation Full Text 
IL –17 Interleukin –17 
TNF Tumor necrosis factor 
ICAM Intracellular adhesion molecule 
BFT Bacteroides fragilis toxin 
LPS Lipopolysaccharide 
CDC Center for Disease Control 
LT Lethal toxin 
HT Hemorrhagic toxin 
AAD Antibiotic-associated diarrhea 
ETBF Enterotoxigenic strains of B. fragilis 
DNA Deoxyribonucleic acid 
PCR Polymerase chain reaction 
SPS Sodium polyanethol sulfonate 
S Susceptible 
R Resistant 
MID Mast identification 
H202 Hydrogen peroxide 
PACA ρ-dimethylaminocinnamaldehyde 
LV Lecitho-vitellin 
KNO3 Potassium nitrate 
RNA Ribonucleic acid 
Km Kanamycin 
Vm Vancomycin 
MIC Minimum inhibitory concentration 
CLSI Clinical Laboratory Standards Institute 
NCCLS National Committee for Clinical Laboratory Standards 
ICU Intensive care unit 
PBP Penicillin-binding proteins 
Nim Nitromidazole resistance genes 
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gyrA Gyrase 
parC Topoisomerase IV 
Rrna Ribosomal Ribonucleic acid 
kb Kilo bases 
µg Micro grams 
NBU Non-replicating Bacteroides units 
Mv Mili volts 
Eh Redox potential 
µm Micrometer 
FDA Food and drug association 
ml Mili litre 
CMJAH Charlotte Maxeke Johannesburg Academic Hospital 
Mw Molecular weight 
RCMM Robertson’s cooked meat medium 
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1.0 Literature review 
 
 
1.1 Introduction 
 
The broad classification of bacteria as anaerobic, aerobic or facultative anaerobic bacteria 
is based on the types of reactions they employ to generate energy for growth and other 
activities. Aerobic bacteria require molecular oxygen as a terminal electron acceptor in the 
energy building process and cannot grow in its absence. Anaerobes, as opposite, cannot 
grow in the presence of oxygen, which is toxic for them, and they depend on other 
substances as electron acceptors. Anaerobic metabolism is fermentative in which they 
reduce available organic compounds to various end products such as organic acids and 
alcohols. The facultative anaerobic organisms are the most versatile. They preferentially 
utilize oxygen as a terminal electron acceptor, but can utilize energy in the absence of 
oxygen by reducing other compounds such as, a molecule of glucose, which is completely 
catabolized to carbon dioxide and water in the presence of oxygen, that is only partially 
catabolized by a fermentative process in the absence of oxygen. The ability to utilize 
oxygen as a terminal electron acceptor provides organisms with an extremely efficient 
mechanism for generating energy. Understanding the general characteristics of 
anaerobiosis provides insight into how anaerobic bacteria can proliferate in damaged tissue 
and why special laboratory conditions are needed in processing clinical specimens that 
may contain them [53]. 
Anaerobic bacteria are part of normal flora in humans. Important oral anaerobes include 
Fusobacterium nucleatum, Fusobacterium necrophorum, Prevotella oralis, Prevotella 
disiens, Prevotella oris, Prevotella buccae, and Bacteroides forsythus. The microbiology 
of the mouth is complex, and many bacteria are dependant on other species for survival; 
for example, P. melaninogenica requires vitamin K produced by other species, and oral 
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spirochetes are dependent on metabolites produced by Fusobacterium species. Anaerobes 
are associated with the eruption of teeth and the gingival crevices as from childhood [64]. 
 
The anaerobic organisms as part of the gastrointestinal flora are responsible for the 
production of vitamin K demonstrating symbiotic and beneficial effect to the host, at the 
same time as the production of bile by these organisms is useful in fat absorption and 
cholesterol regulation [90]. But once these anaerobic organisms change sites and cause 
severe infections, they are associated with high morbidity and mortality and their outcome 
varies on the anaerobic species. Therefore, antibiotic therapy in conjunction with surgical 
intervention, including debridement of necrotic tissue or amputation of a limb, is strongly 
recommended, particularly in infections such as gas gangrene caused by clostridial species 
as well as in abscesses where antibiotics are less effective [102]. 
 
 
1.2 Classification and characteristics of anaerobic organisms 
1.2.1 Classification of anaerobic organisms 
Classification is based on the gram-stain morphology, the ability of spore formation and 
pigment production (Figure 1). 
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Figure 1: Flowchart classification of anaerobic bacteria 
 
 
 
 
 
 
 
 
 
1.2.2 Characteristics of anaerobic organisms 
1.2.2.1 Non-pigmenting gram-negative bacilli 
a. Bacteroides fragilis, the most common anaerobic organism causing infections in 
humans is a gram-negative bacillus with rounded ends 0.5 to 0.8 µm in diameter 
and 1.5 to 4.5 µm in length. Most strains are encapsulated. Vacuolization or 
irregular staining is common, particularly in broth media. Some pleomorphism also 
may be seen. By electron microscopy, the ultra structure of B. fragilis is similar to 
other gram-negative bacteria. The guanine-cytosine content is 42% [38]. 
 
B. fragilis has receptors for bacteriophage, which are species specific and active         
against most strains. Enzymes and toxins-bacteriocins are produced by strains of B. 
Organism 
Gram-negative Gram- positive 
Bacilli Cocci Cocci Bacilli 
Pigmented Non- pigmented Non-spore formers Spore-formers 
Branching Non-branching 
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fragilis and B. thetaiotamicron. Superoxide dismutase has been found in B. fragilis, 
B. thetaiotaomicron, B. vulgatus, and B. ovatus, with possibility to create tolerance 
to oxygen [39].  
 
b. Members of the genus Fusobacterium are spindle shaped, 5 to 10 µm long, often 
seen in pairs, have parallel sides and rounded ends. The guanine-plus-cytosine 
content ranges from 26 to 34%. Strains of F. necrophorum are elongated or 
filamentous, curved, and possess spherical enlargements and large, free, round 
bodies. Fusobacterium nucleatum is a virulent organism causing necrotizing oral or 
facial infections in severely debilitated or malnourished patients, mainly children. 
The lipopolysaccharide of F. necrophorum has a multilayered external coat 
structure. The endotoxin varies from strain to strain in its content of 2-
ketodeoxyoctanate and sugars [38].  
 
1.2.2.2 Pigmented gram-negative bacilli 
 Prevotella melaninogenica and Porphyromonas asaccharolytica are short coccoid gram-
negative rods; they produce a distinctive pigment (brown to black), which is a heme 
derivative. In addition many strains of P. melaninogenica require vitamin K as well as 
heme [38]. 
  
1.2.2.3 Anaerobic gram-negative cocci 
They are classified in the family Veillonellaceae. Three genera: Veillonella, 
Acidaminococcus, and Megasphaera had long been the members of the family, but in the 
year 2002 a fourth genus (Anaeroglobus germinatus) was described [102]. 
 
 7
 
1.2.2.4 Anaerobic gram-positive cocci  
Those of clinical significance are found in three gram-positive genera (Peptostreptococcus, 
Gemella, and Streptococcus). There are other genera of anaerobic cocci, but they are rarely 
isolated from clinical specimens. Anaerobic cocci may be proteolytic, saccharolytic or 
both. They produce a variety of short-chain volatile fatty acids (i.e., acetic, propionic, 
butyric, caproic, and lactic acids) from the fermentation of simple sugars and amino acids. 
Both P. magnus and P. anaerobius possess species-specific cell wall antigens, compared to 
other anaerobic cocci [104]. 
 
1.2.2.5 Anaerobic gram-positive spore forming bacilli 
The genus Clostridium comprises this phylogenetically heterogeneous group of obligatory 
anaerobic, rod-shaped endospore-forming bacteria, mostly motile and petrichously 
flagellated. The genus includes common free-living bacteria that belong to a group of 
important human pathogens, and can be subdivided physiologically into saccharolytic 
and/or proteolytic species [101]. 
 
a. There have been 11 strains of C. tetani distinguished primarily on the basis of 
flagella antigens. They differ in their ability to produce tetanus toxin 
(tetanospasmin), but all strains produce a toxin that is identical in its 
immunological and pharmacological properties. Tetanospasmin is encoded on a 
plasmid that is present in all toxigenic strains. The bacterium synthesizes the 
tetanus toxin as a single 150kDa polypeptide chain (called the progenitor toxin), 
which is cleaved extracellularly by a bacterial protease into a 100kDa heavy chain 
(fragment B) and a 50kDa light chain (fragment A), which remain connected by a 
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disulfide bridge [98]. Mature organisms loose their flagella and develop a terminal 
spore. Growth of C. tetanus from wounds is not useful in diagnosis, as (1) 
anaerobic cultures may be negative; (2) a positive culture does not indicate whether 
the organism contains plasmid that produces toxin and (3) a positive culture may be 
present without disease in immunocompetent patients [13]. 
 
b. Botulism is a life-threatening neuroparalytic disease caused by antigenically 
distinct, heat-labile toxins of C. botulinum. Although seven toxin types (A, B, C, D, 
E, F and G) are produced by the different strains of C. botulinum, most cases of 
botulism in humans are caused by types A, B, E and F. Of these, type F is the least 
common. Types C and D are associated with botulism in birds and mammals, but 
not in humans. Type C can be subdivided into two types, C1 and C2. Although type 
G organisms have been isolated from autopsy samples of a few individuals who 
died suddenly, it is not clear whether type G organisms cause botulism in humans 
[102]. Botulinum toxin is synthesized as a single polypeptide chain with a 
molecular weight around 150kDa. In this form, the toxin has a relatively low 
potency. The toxin is nicked by a bacterial protease (or possibly by gastric 
proteases) to produce two chains: a light chain (the A fragment) with a molecular 
weight of 50kDa; and a heavy chain (the B fragment), with molecular weight 
100kDa. The chains remain connected by a disulfide bond. The A fragment of the 
nicked toxin, on a molecular weight basis, becomes the most potent toxin found in 
nature [98].  
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c. Clostridium septicum is a spindle-shaped, motile gram-positive rod. The organism 
produces alpha, beta, gamma and delta toxins. The organism is not strongly 
invasive, but has been associated with gas gangrene [105]. 
 
d. Clostridium sordellii was first isolated in 1922 by the Argentinean microbiologist 
Alfredo Sordellii, who named organism as Bacillus oedematis sporogenes on the 
basis of morphology and the marked tissue edema [92]. In 1927, the organism was 
renamed Bacillus sordellii [49]. Two years later, it was shown to be identical to 
Clostridium oedematoides and the name C. sordellii was adopted [56]. Similarities 
in morphology and biochemical profile suggested that C. sordellii was simply a 
virulent strain of Clostridium bifermentans; however, urease production by C. 
sordellii clearly distinguished the two species [33]. In the late 1970’s C. sordellii 
antitoxin was found to neutralize the cytotoxic effect of stool specimens collected 
from patients with Clostridium difficile associated pseudomembranous colitis. 
Colonies of C. sordellii appear translucent to opaque with small zones of β- 
hemolysis on sheep or rabbit blood agar [5]. 
 
e. C. difficile, a gram-positive, spore-forming, toxin-producing bacillus, was first 
described in 1935 as a component of the intestinal flora in healthy newborn infants. 
The role of C. difficile in human disease was not appreciated until the 1970’s, when 
it was identified as the causative agent of pseudomembranous colitis.  
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1.2.2.6 Anaerobic gram-positive non-spore-forming bacilli 
Include species of Actinomyces, Bifidobacterium, Arachnia propionica, Lactobacillus, 
Mobiluncus, Eubacterium and Propionibacterium of which the former three produce 
branching characteristics [102]. Actinomyces and P. propionicum are irregular, nonspore-
forming, gram-positive rods. Actinomyces contains 19 species, of which A. israelii and A. 
gerencseriae are the most common human pathogens [16]. Gram-stained smears prepared 
from lesions shows characteristic sulphur granules, which present granular microcolonies 
of the organism surrounded by purulent exudate [102]. The genera Actinomyces and 
Propionibacterium are defined by chemotaxonomic tests, e.g., cell wall composition, 
fermentation products, cellular fatty acids; DNA homology; and analysis of their ribosomal 
RNA (rRNA) [16].  
 
  
1.3 Epidemiology  
Anaerobic bacteria are prevalent among the bacterial populations of the human body, 
particularly on mucous membrane surfaces. In the mouth, anaerobes and aerobes are 
present in approximately equal numbers; in the lower intestine, anaerobes outnumber 
aerobes at least 1000 to 1; and on the skin, at least 10 to 1. The current use of more defined 
methods of collection, cultivation and identification of anaerobic bacteria will undoubtedly 
show them to be even more numerous than our present knowledge indicates [39]. 
Anaerobic bacteria are widespread in soil, lake and river sediments, the oceans, sewage, 
foods, and animals [102]. They are saprophytic in nature and are found in humans as part 
of normal flora [39]. Although a number of infections or intoxications due to anaerobic 
bacteria or their toxins arise from exogenous sources such as the soil, the greater part is of 
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endogenous origin arising frequently from the intestinal tract, the mouth, or the female 
genital tract. They colonize skin and mucous membranes. 
 
a. Skin 
The major groups of anaerobic bacteria that colonize the skin are Propionibacterium and 
the anaerobic gram- positive cocci. Clostridium species may also be found on the skin and 
represent transient contamination from the soil or faeces. Anaerobic cocci are found as 
commensal flora on all skin and mucosal surfaces and are, after the gram-negative bacilli, 
the second most common group of anaerobes encountered in human infection [66]. 
Approximately 10-15% of all isolates of anaerobic cocci come from pure culture 
infections, thus indicating that these organisms can be significant pathogens rather than 
innocuous commensals [104]. 
 Propionibacterium acnes are frequent commensals in skin sebaceous glands, hair follicles, 
mouth, upper respiratory tract, and a frequent contaminant in laboratory cultures [43]. A 
role for Propionibacterium acnes in the pathogenesis of acne has been debated for decades, 
but never adequately proven [15].  
Peptostreptococcus species and Veillonella parvula is universally present in the upper 
airways and normally inhabits the mouth, gastrointestinal tract, vagina, and skin in humans 
[66]. Veillonella and the anaerobic/ aerotolerant streptococci are the anaerobic cocci 
isolated most frequently from human bites [104]. 
 
b. Respiratory tract 
The upper respiratory tract and mouth are inhabited by a variety of potentially pathogenic 
anaerobes in large numbers. Aspiration pneumonias and lung abscesses are frequently 
caused by non-spore forming anaerobes such as Bacteroides melaninogenicus, 
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Fusobacterium, anaerobic cocci and Eubacterium. Spirochetes also inhabit the mouth and 
are found in oral and pulmonary disease but their significance is unknown. 
Actinomyces israelii, A. gerencseriae, A. georgiae, A. naeslundii, A. odontolyticus, A. 
meyeri, possibly A. pyogenes and P. propionicus are normal inhabitants of the human 
mouth and are found in saliva, on the tongue, in gingival crevice debris, and frequently in 
tonsils in the absence of clinical disease. Some data suggest that A. israelii may also be a 
common inhabitant of the female genital tract. The natural habitats are not known for the 
more recently described Actinomyces such as A. bernardiae, A. neuii, A. radingae, and A. 
turicensis. Actinomyces bovis is not found in humans and to date, the other species 
described from animals, with the exception of A. pyogenes, have not been found in 
humans.  Actinomycosis occurs worldwide, but the disease appears more often in men than 
in women [16].  
 
c. Gastrointestinal tract 
 The predominant bacteria in the intestinal flora are: Bacteroides fragilis, Bifidobacterium, 
anaerobic coccci and Eubacterium [39]. Bacteroides and Prevotella are abundant on all 
mucosal surfaces and reach their largest concentrations in the tonsillar crypts, the crypts of 
the tongue, dental plaque, and the gingival crevices in the oral cavity; the colon in the 
gastrointestinal tract and the vagina [64]. Bacteroides fragilis constitutes about 1-2% of the 
normal bacterial flora in humans [102]. 
 
d. Genitourinary tract 
There are few studies of the normal flora of the genitourinary tract except for the vagina, 
where the normal flora is a predominantly anaerobic gram-positive non-sporulating 
bacillus. Anaerobic cocci are also commonly found. Although Bifidobacterium and 
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Lactobacilli are the most predominant bacteria present, most of the infections arising from 
the vagina are due to the anaerobic cocci or Bacteroides species [102]. 
 
e. Environment and human distribution  
The genus Clostridium is widely distributed in nature, at present there are more than a 160 
recognized species, but only a few species have been implicated in humans. In general, 
toxigenic or endogenous Clostridium species are recognized as causative agents of food 
poisoning, gas gangrene, tetanus, botulism, ulcerative colitis, septicemia, and postoperative 
infections in humans. In contrast, most environmental clostridia are considered seemingly 
harmless nonpathogenic bacteria [22]. 
The spores of Clostridium tetani are extremely stable in the environment, retaining the 
ability to germinate and cause disease indefinitely. They withstand exposure to ethanol, 
phenol, or formalin, but can be rendered noninfectious by iodine, glutaraldehyde, hydrogen 
peroxide, or autoclaving at 121°C [13]. 
The source of C. sordelli in obstetric/gynecological- associated infections is unknown, 
although two reports have documented prolonged vaginal carriage of C. sordellii in 0.5%-
10% of healthy women, suggesting that some women may be natural C. sordellii carriers 
[72].  
Improperly processed home-canned low-acid vegetables and contaminated meats are the 
usual cause of food-borne botulism. Foods associated with botulism include canned 
asparagus, green beans, garlic in oil, corn, soups, ripe olives, tuna fish, sausage, luncheon 
meats, fermented meats, salad dressings, and smoked fish.  During the canning process, 
foods undergo a heating process and oxygen is removed, leaving the food in an anaerobic 
environment. Certain foods such as meat are able to bind oxygen to create an anaerobic 
environment. Home canning processes for low-acid foods present an extremely high risk 
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because processing times and temperatures are often inadequate and cans or jars may not 
be handled properly.  Strains of C. botulinum can grow between 38°F and 115°F. This 
means that strains can grow at normal refrigeration and higher temperatures, making it 
difficult to prevent bacterial growth and toxin production.  Infant botulism has been linked 
to the ingestion of C. botulinum spores in honey, corn syrup, and other foods. The C. 
botulinum spores germinate, colonize, and produce toxins in the intestinal tract of infants 
(intestinal toxemia botulism). Infants less than one year old lack the proteins in their 
intestines needed to destroy either the vegetative or spore form of C. botulinum, so these 
products are not recommended for infants [35].  
C. difficile is ubiquitous in nature; the organism is more prevalent in the feces of some 
hospitalized adults who do not have diarrhea or colitis. It has been found in the feces of 
about 13-30% of hospitalized adults who were colonized but had no evidence of disease 
caused by C. difficle or antecedent antibiotic treatment [102].  
 
 
1.4 Pathogenesis 
Infections caused by anaerobes are usually a result of the breakdown of a mucosal barrier 
and subsequent leakage of indigenous polymicrobial flora into previously sterile closed 
spaces or tissue. In certain cases, such as aspiration pneumonia, anaerobic bacteria move 
into sterile sites [38]. Few anaerobic bacteria that survive in the infected site are those that 
have resisted changes in oxidation-reduction potential and host defense mechanisms [100]. 
The more aerotolerant anaerobes are more likely to survive after the normally protective 
mucosal barrier is broken and until conditions are satisfactory for their multiplication and 
invasion. Once anaerobes begin to multiply, they can maintain their own reduced 
environment by excreting end products of fermentative metabolism [38]. 
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One of the major defenses of the body against infections by anaerobes is the normal Eh 
(+120 millivolts). Lowering the redox potential permits multiplication of anaerobes within 
tissues [39]. It is interesting to note that anaerobes inhabit areas of the body that are 
exposed to air: the skin, nose, mouth, and throat. It has been hypothesized that anaerobes 
can withstand oxygen at these sites, in part owing to the presence of aerobes and 
facultative organisms, which consume oxygen and reduce oxidation-reduction potential 
[100]. 
 Under anaerobic conditions, the granulocyte phagocytic bactericidal system does not 
function effectively. Lowered oxidation – reduction potential also results from impaired 
blood supply, tissue necrosis and growth of facultative bacteria in a wound. Thus, vascular 
disease, epinephrine injection, cold, shock, edema, trauma, surgery, foreign bodies, 
malignancy, gas production by microorganisms, and aerobic infection may all predispose 
significantly to anaerobic infection [39]. 
 
1.4.1 Virulence factors 
Virulence factors associated with anaerobic infections are:  
(1) Ability to evade host defenses, 
(2) Adherence to cell surfaces, 
(3) Production of toxins and /or enzymes and  
(4) Expression of surface antigens that contribute to pathogenesis [100]. 
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MAJOR BACTERIAL VIRULENCE DETERMINANTS 
 
Figure 2. Virulence determinants. Illustration of the major types of known virulence determinants. A 
pathogen may have one or many virulent determinants. When a pathogen loses a crucial virulence 
determinant it becomes avirulent. Conversely, a normally non-virulent microbe may gain virulent 
genes and suddenly become virulent or a mildly pathogenic strain may gain an additional virulence 
determinant and become virulent. 
 
[57] 
 
 
1.4.1.1. Ability to evade host defences 
 
Pathogens frequently cause disease by changing normal functions of the host cells. One 
way is to induce the host system to produce self-destructive chemicals that kill or inhibit its 
own cells. In doing this the body's own defence system is redirected towards its own 
destruction, leaving the invading pathogen to the nutritious remains. In fact many of the 
"diseases" caused by both viruses and bacteria are the result of the pathogen disrupting the 
normal processes of the host and escaping destruction or detection [57]. 
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1.4.1.2. Adherence to cell surfaces 
To avoid phagocytosis, many pathogens have evolved surface components that prevent the 
attachment and engulfment of macrophages and other host cellular immune responses. This 
may take the form of membrane bound proteins, slimy polysaccharide capsules, or "self" 
moieties scavenged by the microbe and bound to its cell surface [14]. Gram- positive 
bacteria are surrounded by a thick cell wall that has a low permeability to the surrounding 
environment, while gram- negative bacterial lipopolysaccharide (LPS) or "endotoxin" can 
protect against complement-mediated lysis. In addition, several antigens produced by both 
classes can inhibit adsorption [29]. 
Since many of the non-specific defences involve mechanically flushing away pathogens, a 
common virulence determinant of pathogens are cell components that stick the bacteria to 
the target cells. Like the attachment of viruses, these systems stick to each other. Two 
general attachment systems have been established: 
a) The pili are short protein rods or curled protein strands that have binding proteins on the 
ends that attach firmly to receptor molecules on the surface of other host cells. 
b) Capsules, on the other side are composed of sugar polymers (occasionally of protein 
polymers) [57].  
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[57] 
The first host barrier for many invading pathogens is usually a mucosal surface, such as the 
gut or respiratory tract. Since epithelial cell turnover is around 48 hours in these 
environments, the bacterium must attach and replicate sufficiently to avoid being swept 
away. Therefore, many have evolved motile or attachment elements like flagella and 
pili/fimbriae to cross the barrier and invade [86]. Simple attachment is mediated through a 
receptor on the host cell surface, and an adhesion on the bacterial one. Some may be 
species or even strain specific, while others exhibit tissue tropism or include the fimbrial 
protein subunit that binds D-mannose on host cell surfaces [71]. 
1.4.1.3 Production of toxins and or enzymes 
Toxins are products of a pathogen that destroy one or more vital component of the host 
thus allowing the pathogen to survive and grow. 
 
a) Secreted by viable pathogenic cells, bacterial protein exotoxins are amongst the most 
potent toxins known. Often encoded for by bacteriophage or plasmid, there are many 
classes and all are strongly antigenic but inherently unstable. Some act on host cell 
surfaces, while the majority (A/B toxins) bind to the target membrane with a receptor (B 
 
Figure 3. Attachment system that bind pathogens to their 
hosts. On the left binding proteins, usually pili, of the pathogen 
attach to the receptor molecules on the surface of the host cells. 
The pathogen may simply use this as an anchor by which it 
keeps from being flushed away by a flow of material or this may 
be the first step in destroying the target cell. On the right 
bacteria are shown embedded within a capsule that, along with 
pili, binds to each other and to the surface of a target cell. Again, 
the bacterial cells may use this as a way of not being washed 
away or it may be the preliminary step in a process that leads to 
the death of the target cell.  
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subunit) and deliver a second moiety (A subunit) directly into the cytoplasm [4]. More 
specialized toxins involve "injection" of the protein into the host via a unique "type III" 
secretion system. The latter is only found in some gram- negative enteropathogens [55]. 
Toxins can also be grouped according to their biological activity in certain cells, such as 
leukotoxins and neurotoxins. These toxins are secreted from the cell or leak out of the cell 
after it dies. Generally they are soluble proteins and thus are carried throughout the body in 
the blood or lymph, doing damage at a distance from the infection site. Toxins tend to 
target specific cells in the body. Some are enzymes and others are proteins that bind to and 
inhibit crucial cellular activities that eventually lead to the death of cells [57]. 
  
b) Endotoxins produced by gram- negative bacteria have a general basic structure, but   
differ significantly in composition between species. Endotoxins are released in relatively 
small amounts as the cells grow, but in abundant amounts when the cells die. Different 
endotoxins differ in their degree of toxicity, but all are heat stable and can tolerate 
autoclaving [57]. Endotoxin or lipopolysaccharide (LPS) activates the host complement 
pathway, and is a potent inducer of inflammation. It is an outer membrane chemical moiety 
consisting of three sections: a toxic lipid (Lipid A) anchored in the outer membrane, an 
immunogenic polysaccharide core, and an antigenic O-linked series of oligosaccharides at 
the extracellular surface. It is considered a part of gram- negative bacterial pathology [34]. 
Endotoxins are toxic to most mammals, and can be lethal if encountered in too high a dose. 
Specifically, release of LPS into the host circulation promotes binding by a certain protein, 
dubbed "LPS-binding complex". This interacts with CD14 receptors on a variety of 
monocytes and macrophages, triggering inflammatory cytokine release, and activation of 
the complement and coagulation cascades [106]. They are often responsible for the cause 
of death of infections by gram-negative cells [57]. 
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c) Enzymes affect physical barriers like tissue matrices and cell membranes. In this way, 
the bacterium can quickly spread through intercellular spaces [94]. There are several 
classes of invasive enzymes; while some dissolve strong tissues like the hyaluronic 
component of connective tissue other proteins creates holes in cell membranes and cause 
cell lysis (lecithinases and phospholipases). Other obligate intracellular bacterial proteins 
have been called "invasins" and act exclusively on host actin filaments and induce 
engulfment of the microbe for colonization. 
 
1.4.1.4 Expression of surface antigens that contribute to pathogenesis 
Pathogens often evade a host's immune system by frequently changing its surface antigens. 
For example, HIV and malaria use this strategy to avoid destruction. In these cases a 
pathogen produces a few antigenic variants as its population increases. Meanwhile the host 
responds by making antibodies only against the major antigenic form. However, the 
variant(s) survives, thrives and increases in number, while continuing to harm the host. The 
host will then mount a second vigorous antibody attack against the new variant only to 
have another new variant escape. Eventually, the pathogen does so much damage that the 
weakened host is destroyed.  
Furthermore a pathogen may hide from host defence cells.  One way is to coat itself with a 
capsule which the white blood cells either doesn't recognize or for some other reason 
avoids ingestion thus allowing the capsule-covered pathogen to remain free and 
unhindered. In other cases the pathogen may enter and hide within host cells, thus escaping 
the ingestion of white blood cells and their antibodies. Some pathogens have even 
 21
developed ways of moving from one host cell to another without coming out of the cell so 
they avoid detection by the defending immune system [57]. 
 
 
 1.4.2 Pathogenicity of the gram-negative bacteria 
 
 
Bacteroides, Prevotella, Porphyromonas, and Fusobacterium species may have the 
possibility to penetrate tissues and then to cause infection under certain circumstances such 
as surgical or other trauma or when tumors arise at the mucosal surface [38]. 
 
1. Bacteroides species produce many enzymes and toxins that contribute to 
pathogenicity. Enzymes such as neuraminidase, protease, glycoside hydrolases, and 
superoxide dismutases are all produced by B. fragilis. Also, this organism produces 
an entero-toxin with specific effects on host cells in vitro. This toxin, termed BFT 
(Bacteroides fragilis toxin), is a metalloprotease that is cytopathic for intestinal 
epithelial cells and induces fluid secretion and tissue damage in ligated intestinal 
loops [100]. Neuraminidase alters neuraminic acid-containing glycoproteins of 
human plasma; Bacteroides strains isolated from sterile sites have higher 
neuraminidase activity than do those isolated from stools, and strains of the B. 
fragilis group have greater activity of this type than do strains of other gram-
negative anaerobic bacillary species. Hyaluronidase is produced by many stains of 
the B. fragilis group and pigmented gram-negative rods. DNAse is also produced 
by B. fragilis and may be an important factor in infection. Many gram-negative 
anaerobic bacilli produce phosphatase. A heparinase produced by B. fragilis strains 
may contribute to intravascular clotting and hence increase the dosage of heparin 
needed for the treatment of septic thrombophlebitis in infections caused by this 
organism [38]. The septic thrombophlebitis commonly seen in anaerobic infections 
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may result from production of heparinase by anaerobic bacteria. This lesion may 
lead to metastatic abscesses and helps account for the difficulty in eradicating 
anaerobic infections [39]. The lipopolysaccharides of B. fragilis, B. vulgatus, and 
F. mortiferum activate the Hageman factor and thereby initiate the intrinsic 
pathway of coagulation. Fibrinolysin is produced by many P. melaninogenica 
group strains and by a few B. fragilis strains. Strains of Bacteroides and P. 
gingivalis degrade complement factors and immunoglobulins G and M [38]. 
The pathogenicity of B. fragilis is related to its carbohydrate capsule, outer 
membrane proteins, several enzymes and the enterotoxin called fragilysin [31]. 
Biologic and molecular studies of this virulence factor show that B. fragilis produce 
            at least eight distinct capsular polysaccharides [62] they have been identified as 
            major virulence factors and has a specific central role in the formation of  
            abscesses [77]. 
Figure 4: Capsule of B. fragilis 
 
[85] 
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         These polymers activate host CD4 cells and promote the release of interleukin 17 
         (IL-17). In addition, the capsule induces the release of the pro-inflammatory 
         cytokines tumor necrosis factor-α (TNF-α) and IL-1β from peritoneal macrophages. 
         These cytokines poteniate the increase of cell adhesion molecules such as  
         intracellular adhesion molecule-1 (ICAM-1) on mesothelial cell surfaces, which in    
         turn leads to an increase in the binding of neutrophils to these cells and initiates  
         abscess formation [100]. Pili (fimbriae) and lectin like adhesions may also be  
         important in the adherence of Bacteroides cells to epithelial surfaces. Butyrate and  
         succinate produced by Bacteroides show a cytotoxic effect [38].  
         Additional studies indicate that anaerobes can produce compounds such as succinic 
         acid and short-chain fatty acids that inhibit the ability of phagocytes to clear  
         facultative organisms [76]. Enterotoxigenic strains of B. fragilis (ETBF)  
         produce a zinc-containing metalloprotease of 44.4kDa, which induces fluid  
         accumulation in ligated intestinal loops and morphologic changes in HT-29 cells.  
         ETBF has been found to cause diarrhea in animals and humans, especially children.  
         The isolation of ETBF from 20.3% of diarrhea specimens from children in rural 
         Bangladesh has been reported [26]. 
 
2.  Prevotella species produce proteases- IgA proteases and metabolic products such as  
     volatile fatty acids and amines. The degradation of IgA produced by mucosal surfaces 
     allows Prevotella to evade this first line of host defence [100]. Prevotella  
     melaninogenica is one of the few bacteria that produce collagenase. Porphyromonas 
     gingivalis also produces collagenase and has trypsin-like activity.  Porphyromonas 
     asaccharolytica produces proteinases that render it capable of hydrolyzing gelatin, 
     casein, coagulated protein, plasma protein, azacol, and collagen. A strain of P. 
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     melaninogenica produces phospholipase A [38]. 
 
3.  P. gingivalis possess a large number of virulence determinants, such as fimbriae and  
     proteases [103]. It induces tissue destruction by the elevation of tumor 
     necrosis factor (TNF) levels [65]. The bacterium has been shown to possess 
     various bioactive components including a cytoplasmic membrane, peptidoglycan, outer- 
     membrane proteins, LPS and fimbriae on its cell surfaces [75]. These  
     components have been demonstrated to induce multiple cytokines in periodontal tissues  
     [54]. The abilities of P. gingivalis to adhere to and invade host tissue, e.g.  
     epithelial cells, endothelial cells, and gingival fibroblasts, as well as to express powerful 
     lytic enzymes may also play a role in the destruction of the periodontal tissue [8].  
     Deshpande et al [30] indicated the existence of an association between P. 
     gingivalis and cardiovascular disease because of the bacterium’s ability to multiply in 
     and activate endothelial cells. Lipopolysaccharide from P. gingivalis stimulates  
     cytokine secretion in immune cells and initiates the inflammation associated with  
     periodontitis [40]. 
 
4. F. necrophorum causes tissue necrosis in the oral cavity. Toxins such as leukotoxin,  
    endotoxin, and hemolysin have been implicated as virulence factors. Both F. nucleatum  
    and F. necrophorum produce a potent LPS (lipopolysaccharide) that is responsible for 
    the release of numerous pro-inflammatory cytokines and other inflammatory mediators 
   [100]. Certain F. necrophorum hemagglutinate the erythrocytes of humans. A  
    bovine isolate of F. necrophorum demonstrates lysophospholipase activity. 
    Fusobacterium gonidiaformans produces an appreciable inflammatory reaction when  
    inoculated into the skin of rabbits; when injected intra-peritoneally into mice, it leads to 
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    liver abscesses and occasionally to death. A specific toxin has not yet been isolated  
   Fusobacterium necrophorum may persist in Kupffer cells and impair macrophage  
    functions [38].  
 
5. The gram-negative anaerobe Veillonella is a common isolate in microbiological 
    characterizations of human dental plaque and gingival crevices. The lipopolysaccharide 
    (LPS) of this organism is highly endotoxic to mammalian tissue and has been implicated  
    in the development of periodontal disease [99]. 
 
 
1.4.3 Pathogenicity of the gram-positive bacteria 
 Certain toxins account for the virulence of some anaerobic infections and cause serious     
intoxication without infection. 
 
1. Tetanospasmin initially binds to peripheral nerve terminals. It is transported within 
the axon and across synaptic junctions until it reaches the central nervous system. 
There it becomes rapidly fixed to gangliosides at the presynaptic inhibitory motor 
nerve endings, and is taken up into the axon by endocytosis. The effect of the toxin 
is to block the release of inhibitory neurotransmitters (glycine and gamma-amino 
butyric acid) across the synaptic cleft, which is required to inhibit nervous impulse. 
If nervous impulses cannot be checked by normal inhibitory mechanisms, it 
produces the generalized muscular spasms characteristic of tetanus. Tetanospasmin 
appears to act by selective cleavage of a protein component of synaptic vesicles, 
synaptobrevin II, and this prevents the release of neurotransmitters by the cells.  
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The receptor to which tetanospasmin binds has been reported as ganglioside GT 
and/or GD1b. Binding appears to depend on the number and position of sialic acid 
residues on the ganglioside. Isolated B fragments, but not A fragments, will bind to 
the ganglioside. The A fragment has toxic (enzymatic) activity after the B fragment 
secures its entry. Binding appears to be an irreversible event so that recovery 
depends on sprouting a new axon terminal [98]. 
2. The botulinum toxin is specific for peripheral nerve endings at the point where a       
motor neuron stimulates a muscle. The toxin binds to the neuron and prevents the     
release of acetylcholine across the synaptic cleft. The heavy chain of the toxin    
mediates binding to presynaptic receptors. Different toxin types seem to utilize   
slightly different receptors. The binding region of the toxin molecule is located    
near the carboxy terminus of the heavy chain. The amino terminus of the heavy 
chain is thought to form a channel through the membrane of the neuron allowing 
the light chain to enter. The toxin (A fragment) enters the cell by receptor-mediated 
endocytosis. Once inside a neuron, different toxin types probably differ in 
mechanisms by which they inhibit acetylcholine release. The affected cells fail to 
release a neurotransmitter, thus producing paralysis of the motor system. Once 
damaged, the synapse is rendered permanently useless. The recovery of function 
requires sprouting of a new presynaptic axon and the subsequent formation of a 
new synapse [98].  
 27
 
Figure 5: Action of botulinum toxin on a neuromuscular junction [89]. 
 
3. Clostridium perfringens produces the alpha-toxin, a potent lecithinase that causes 
haemolysis and necrosis. Other toxins include collagenase, hyaluronidase, 
deoxyribonuclease and proteinases [39]. Among the 12 toxins produced by C. 
perfringens are four major lethal toxins that are used to divide the species into five 
serologic types classified A to E. Additional virulence factors include enterotoxin, 
neuraminidase (sialidase), non-α-δ-θ-hemolysins, and the organism’s vigorous 
metabolic activity [63]. As the clostridia multiply, various exotoxins (including 
hemolysins, collagenases, proteases, and lipases) are released into the surrounding 
tissue, causing local tissue necrosis, ischemia, gas formation, muscle involvement 
and systemic toxemia. As capillary permeability increases, the accumulation of 
fluid increases, and venous return is reduced, more tissue becomes involved, and 
clostridia release more toxins into the local tissue and the systemic circulation 
[105].  
 
4. Virulence of C. sordellii is attributed to numerous exotoxins, although only 2, the 
lethal toxin (LT) and hemorrhagic toxins (HT) have been extensively studied. 
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Pathogenic strains of C. sordellii produce up to 7 identified exotoxins. Of these, 
lethal toxin and hemorrhagic toxin are regarded as the major virulence factors. 
Other exotoxins include an oxygen-labile hemolysin, neuraminidase, DNAse, 
collagenase, and lysolecithinase. The roles of these toxins in pathogenesis have not 
been extensively investigated [92]. 
 
5. Actinomycosis results when bacteria resident in the mouth are introduced into the 
tissues. The mechanisms by which Actinomyces and P. propionicum produce 
disease are not clear. Pathogenesis may involve the ability of these organisms to 
suppress some of the immune functions of the host. Studies of oral disease have 
shown that Actinomyces are chemotactic, activate lymphocyte blastogenesis, and 
stimulate the release of lysosomal enzymes from polymorphonuclear leukocytes 
and macrophages. With the exception of A. pyogeneswhich produces a soluble 
toxin and a hemolysin that can be neutralized by antiserum, Actinomyces and 
P.propionicus do not produce exotoxins or significant amounts of other toxic 
substances [16]. Actinomycosis is almost always a mixed infection; a variety of 
other oral bacteria can be found in the lesion with Actinomyces or P. propionicus. 
The role of these associated bacteria is not clear. It has been shown that succinic 
acid produced by Actinomyces can promote the growth of some gram-negative 
anaerobes. In experimental infections, Eikenella corrodens and Actinobacillus 
actinomycetemcomitans enhance the virulence of Actinomyces. The mycelial 
masses of Actinomyces reduce the rate of penetration of antibiotics and may 
physically protect the associated bacteria. In addition, associated organisms that 
produce ß-lactamases can complicate treatment. Therefore, the dense granules of 
Actinomyces and the presence of associated bacteria can enhance the virulence of 
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the infection and influence the mode of use of antibiotics, thereby adding to the 
difficulty of treating the disease [16].  
 
 
1.5 Clinical manifestations    
Anaerobic infections generally occur in patients who have impaired host defense 
mechanisms. Disruption of natural barriers such as the skin and mucous membranes, 
diabetes mellitus, connective tissue disorders, atherosclerotic disease, cancer (especially of 
the colon, uterus, and lung), irradiation damage, immunosuppressive treatment, and 
alcoholism predispose to anaerobic infections [39]. 
Anaerobic bacteria can cause infection practically anywhere in the body: 
Figure 6: Types of anaerobic infections occurring in the human body. 
 
[38] 
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• Mouth, head, and neck: Infections in the root canals, gums (gingivitis), jaw, 
tonsils, throat, sinuses, and ears.  
• Lung: pneumonia, lung abscesses, infection of the lining of the lung (empyema), 
and dilated lung bronchi (bronchiectasis).  
• Intra abdominal: abscess formation, peritonitis, and appendicitis.  
• Female genital tract: pelvic abscesses, pelvic inflammatory disease, inflammation 
of the uterine lining (endometritis), and pelvic infections following abortion, 
childbirth, and surgery.  
• Skin and soft tissue: diabetic skin ulcers, gangrene, destructive infection of the 
deep skin and tissues (necrotizing fascitis), and bite wound infections.  
• Central nervous system: brain and spinal cord abscesses.  
• Bloodstream: bacteraemia. 
 
1.5.1 Clinical characteristics of infection caused by the anaerobic gram-negative 
         bacilli 
 
The clinical characteristics of infection with Bacteroides, Prevotella and Fusobacterium 
are similar, they include foul-smelling discharge, located in mucosal surfaces, cause tissue 
necrosis with gas production or discharges, associated with infections in cancer patients, 
infection related to the use of aminoglycosides or other agents with poor activity against 
anaerobes, septic thrombophlebitis and infection following human or animal bites [38].  
 
B. fragilis one of the most common cause of anaerobic bacteremia, has been recognized as 
an organism with a potential mortality of 19% [80]. However, B. ovatus is occasionally 
isolated from the blood of compromised patients with poly-microbial bacteremia secondary 
to trauma or necrosis of the bowel [102]. 
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The clinical presentation of F. necrophorum sepsis is distinctively characterized by sore 
throat and fever often accompanied by chills. A membranous tonsillitis with foul odour to 
the breath may be noted, and in the absence of effective therapy, bacteremia and 
widespread metastatic infections occurs [38]. 
 
Porphyromonas gingivalis, a black-pigmented rod, is considered to be associated with 
chronic periodontal disease [91]. P. gingivalis is a fastidious bacterium that can be detected 
more effectively by PCR (Polymerase chain reaction) than by culture and may need a 
longer incubation period than the 7 days applied in routine diagnostics [46]. Also this 
bacterium is considered to be the most pathogenic bacterium of all periodontal mixed 
anaerobic organisms that are part of normal flora [103]. It colonizes root canals in chronic 
apical periodontitis and is usually involved in periodontal diseases, which are characterized 
by alveolar bone loss [41]. 
 
1.5.2 Clinical characteristics of infection caused by the anaerobic gram- positive  
          bacilli 
 
1. Actinomycosis is a chronic disease characterized by the production of suppurative 
abscesses or granulomas that eventually develop draining sinuses. These lesions 
discharge pus containing the organisms. In long-standing cases, the organisms are 
found in firm, yellowish granules called sulphur granules. The disease is usually 
divided into three major clinical types: 
• Cervicofacial- infections involve the face, neck, jaw, or tongue and usually 
occur following an injury to the mouth or jaw or a dental manipulation such 
as extraction. The disease begins with pain and firm swelling along the jaw.   
• Thoracic- results from aspiration of pieces of infectious material from the 
teeth and may involve the chest wall, the lungs, or both. The symptoms are 
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similar to those of other chronic pulmonary diseases, and the disease is 
often difficult to diagnose. Thoracic disease may spread extensively to 
adjacent tissues or organs and often disseminates through the bloodstream, 
resulting in abscesses in distant sites such as the brain.  
• Abdominal- often associated with abdominal surgery, accidental trauma, or 
acute perforative gastrointestinal disease. Persistent purulent drainage after 
surgery or abdominal masses resembling tumours may be the first sign of 
infection.   
Primary infections may involve almost any organ. Secondary spread of the disease 
is by direct extension of an existing lesion without regard to anatomic barriers.  
Actinomyces and P. propionicus cause a lacrimal canaliculitis with concretions in 
the canaliculi that are persistent. A. naeslundii and A. odontolyticus can also infect 
the eyes. In recent years, Actinomyces and P. propionicus have been isolated with 
increasing frequency from female pelvic infections associated with wearing an 
intrauterine contraceptive device [16].  
 
2. Propionibacterium propionicum may resemble certain species of Actinomyces and 
it may be associated with human actinomycosis; cases involving neck abscess, a 
finger wound infection following a human bite, renal abscess, and lacrimal 
canaliculitis [102]. 
  
3. Propionibacterium acnes, an underestimated but significant cause of post -
neurological infection, especially in the chronic sub-dural haematoma or cerebral 
tumor [43]. It is also known to be one of the most frequent causes of post-surgical 
endophthalmitis [88]. Severe infections due to P. acnes are rarely reported but it is 
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increasingly recognized as a cause of a number of infections, such as endocarditis, 
prosthetic joint infection, endophthalmitis, osteomyelitis, and central nervous 
system infections [20]. To the patients with an indwelling medical device such as a 
prosthetic heart valve, cerebrospinal fluid shunt or intra-ocular lens 
proprionibacteria may be involved.  
 
4.  Eubacteria have been recognized as pathogens in infections of the female genital 
tract associated with intrauterine devices. They have been recovered from pleuro-
pulmonary infections, (brain) abscesses, and osteomyelitis of the skull, peritonitis, 
wound infections, chronic periodontal infections, decubitus ulcers, and bites. 
Occasionally they have been reported as a cause of clinically significant bacteremia 
in patients with malignancies, gastrointestinal or obstetric disorders, and 
endocarditis. 
 
5. Blood stream infections by bifidobacteria are diagnosed rarely, usually along with 
other organisms, in patients with complications associated with childbirth, 
gastrointestinal disorders, malignancies, or systemic lupus erythematosus. 
Involvement of bifidobacteria species has occasionally been reported in chronic 
otitis media, pleuro-pulmonary infections, cholesteatoma, peritonitis, abscesses in 
the head and neck, meningitis, and paronychia. 
 
6.   Lactobacteria have been involved in pleuro-pulmonary infections, (intra 
abdominal) abscesses, meningitis, conjunctivitis, dental caries, and endometritis. 
Several studies have indicated a protective effect of lactobacilli and bifidobacteria 
against potential pathogens in the gastrointestinal tract, linked to prevention of 
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colon cancer in several animals. Therefore, they have been in use as base of so-
called probiotics, which are identified as bacteria that provide specific health 
benefits when consumed as a food component or supplement [67]. 
 
7.  Clostridial wound infections may be divided into three categories namely gas 
gangrene/ clostridial myonecrosis, anaerobic cellulites and superficial 
contamination. Gas gangrene has a rapidly fatal outcome and requires urgent 
treatment [105]. Features of clostridial organisms are the production of gas at the 
infected site, activity of specific toxins and rarely massive intra-vascular hemolysis 
[63]. Initially tissue damages with impaired blood supply, the fever and edema, 
foul- smelling exudates and gas bubbles are products of anaerobic fermentation. 
Clostridial septicemia, although rare, may complicate in the late stages of the 
disease. Severe shock with massive hemolysis and renal failure is usually the 
ultimate cause of death. The incubation period, varies from 1 to 6 days, but it may 
be as long as 6 weeks. Average incubation times for the three most prevalent 
anaerobic organisms are for C. perfringens 10-48 hours, C. septicum 2-3 days and 
C. novyi 5-6 days, therefore the appropriate antimicrobial treatment is important to 
start as soon as possible to prevent development of gas gangrene. Clostridial 
cellulites, an infection of muscle tissue, with a more gradual onset than gas 
gangrene and appear without the systemic toxemia. Anaerobic cellulites may cause 
formation of gas bubbles, similar to gas gangrene. Some tissue necrosis does occur, 
caused by decreased blood supply and not invasion with the anaerobic organism. 
With appropriate treatment, anaerobic cellulites have a good prognosis [105].  
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8.  Antibiotic-associated diarrhea (AAD) is a significant cause of morbidity and 
mortality, particularly in the hospitalized patients.  People in good health usually do 
not get C. difficile disease. C. difficile produces two toxins: Toxin A is referred to 
as an enterotoxin because it causes fluid accumulation in the bowel. Toxin B is an 
extremely lethal (cytopathic) toxin [98]. Antimicrobial agents implicated in C. 
difficile-associated gastrointestinal illness have included aminoglycosides, 
penicillin’s, cephalosporins, clindamycin, erythromycin, linomycin, 
trimethoprimsulfamethoxazole, amphotericin B, rifampin and the fluoroquinolones 
[102]. C. difficile has been implicated in: 
a. Pseudomembranous colitis;  
b. Diarrhea associated with methotrexate treatment and other anticancer 
chemotherapeutic agents;  
c. Relapses of nonspecific inflammatory bowel disease (e.g., Crohn’s disease; 
ulcerative colitis); 
d. Obstruction or strangulation of the bowel and  
e. A few cases of sudden infant death syndrome [102]. 
 
9.   C. tertium is an aero-tolerant anaerobic organism that is usually considered 
      nonpathogenic however; there are scattered reports of this organism causing 
      bacteremia. Most cases have involved neutropenic patients, and the gastrointestinal  
      tract appears to be the source of infection. It is possible that this organism causes many 
      more cases of bacteremia than is currently appreciated as its aero-tolerant nature may  
      result in its misidentification as a Bacillus species [105]. 
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10.Clinical presentations of botulism are categorized by the CDC (Center for  
     Disease Control) as:  
a. Foodborne- seen in adults from the ingestion of preformed toxin in contaminated 
food [102]. Clinical symptoms of botulism begin 18-36 hours after toxin ingestion 
with weakness, dizziness and dryness of the mouth. Nausea and vomiting may 
occur. Neurologic features soon develop, including blurred vision, inability to 
swallow, difficulty in speech, descending weakness of skeletal muscles and 
respiratory paralysis [98].  
b. Wound -results from production of botulinum toxin in an infected wound,  
c. Infant - seen most commonly with production of the neurotoxin within the infant 
gut [102]. The disease occurs in infants 5 - 20 weeks of age that have been exposed 
to solid foods, presumably the source of infection (spores). It is characterized by 
constipation and weak sucking ability and generalized weakness. The possible role 
of infant botulism in "sudden infant death syndrome-SIDS" has been suggested but 
remains unproven. C. botulinum, its toxin, or both have been found in the bowel 
contents of several infants who have died suddenly and unexpectedly [98].  
d. Undetermined (is identified in individuals who are older than 12 months, where no 
food or wound source of C. botulinun can be implicated [102].  
Regardless of which antigenic type of C. botulinum (i.e. A, B, D, or E), is involved it 
may produce toxin which binds to synaptic vesicles of cholinergic nerves, preventing 
the release of acetylcholine at the peripheral nerve (including neuromuscular junctions) 
and consequently acute, flaccid, descending paralysis develops. The paralysis begins 
with bi-lateral impairment of cranial nerves resulting in paralysis of muscles of the face 
(including eyelids), head, and throat, than descends symmetrically to involve the 
muscles of the thorax, diaphragm, and extremities. Patients may die of respiratory 
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paralysis unless they have proper respiratory intensive care, including mechanical 
ventilation; death may also result from secondary pneumonia (caused by non-
botulinum organisms) [13].  Confirmation of the clinical diagnosis of botulism is 
demonstrated by presence of botulinum toxin (mouse neutralization test) in serum or 
faeces, and/or C. botulinum in faeces. Isolation and identification of the organism is by 
conventional cultural biochemical procedures and the toxin neutralization test. Toxin 
has only rarely been detected in serum from an affected infant [102].  Toxin excretion 
may continue up to 1 month after the onset of illness, and stool cultures may remain 
positive for a similar period [13]. 
 
11. Tetanus is a severe disease caused by the toxin of C. tetani [105]. Most cases  
     of tetanus result from small puncture wounds or lacerations, which become 
     contaminated with C. tetani spores that germinate and produce toxin. The infection 
     remains localized, often with only minimal inflammatory damage. The toxin is  
     produced during cell growth, sporulation and lysis. It migrates along neural paths  
     from a local wound to sites of action in the central nervous system [98]. The 
     initial symptom is cramping and twitching of muscles around a wound. The patient 
     usually has no fever but sweats profusely and begins to experience pain, especially  
     in the area of the wound and around the neck and jaw muscles (trismus) [105]. 
     The characteristic symptom of "lockjaw" involves spasms of the masseter muscle. 
     Spasms of the pharyngeal muscles cause difficulty in swallowing [98]. Portions 
     of the body may become extremely rigid, and opisthotonos (a spasm in which the head 
     and heels are bent backward and the body bowed forward) is common [105]. In acute 
     onset a very large number of patients die [13]. Death usually results from interference 
     with mechanics of respiration [98].  
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     Complications include fractures, bowel impaction, intramuscular hematoma,  
     muscle ruptures, pulmonary, renal and cardiac problems [105].   
 
 
Figure 7: Soldier dying of tetanus. 
 
Sir Charles Bell's portrait of a soldier dying of tetanus. The characteristic rigidity of 
the body is referred to as opisthotonos and risus sardonicus [98].   
 
12. Although most Clostridium species are not generally considered to be invasive, C. 
clostridioforme organisms have been isolated from bone, blood, liver abscesses, 
sub gingival areas, and foot (in diabetic patients) [107]. 
  
13. Clostridium ramosum is a member of the large bowel flora and is the second most 
common clostridium isolated from properly collected clinical specimens. It is 
common in intra abdominal infections following trauma and especially important 
clinically because of its resistance to penicillin G, clindamycin, and other 
antibiotics [102]. 
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14.  Clostridium novyi type A has been associated with an outbreak of serious illness 
and death amongst intravenous drug users. Clostridium histolyticum infections were 
also reported in this group of patients [101]. 
 
15. Many strains of C. sordellii are nonpathogenic; however, virulent strains cause 
lethal infections in several animal species, such as enteritis and enterotoxaemia in 
sheep and cattle [24]. 
 
 
1.5.3 Clinical characteristics of infection caused by the anaerobic cocci 
Anaerobic cocci are not involved in specific disease process; rather, these infections may 
range in severity from mild skin abscesses, which disappear spontaneously after incision 
and drainage, to more serious and life-threatening infections such as brain abscess, 
bacteremia, necrotizing pneumonia, and septic abortion. Brain abscess, with a mortality 
rate of 40%, is one of the more serious infections involving anaerobic cocci that have been 
isolated in pure culture. Chronic otitis media or mastoiditis frequently, is the primary 
source of these organisms and may result as a direct extension of the infection into the 
brain. Pleuropulmonary infection, sinusitis, congenital heart defects, and bacterial 
endocarditis are other conditions predisposing individuals to brain abscess by blood-borne 
metastases.  
Pleuropulmonary infections in which anaerobic cocci may be etiologic agents are lung 
abscesses, necrotizing pneumonia, aspiration pneumonitis, and empyema. The incidence of 
anaerobes in these infections is 50-90%; anaerobic cocci account for about 40% of the 
anaerobic isolates. 
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They are also involved in several skin and soft tissue infections that may be confused with 
clostridial myonecrosis (gas gangrene). These infections are identified as anaerobic 
streptococcal myonecrosis, progressive bacterial synergistic gangrene, necrotizing fasciitis, 
crepitant cellulitis, chronic burrowing ulcer, and synergistic necrotizing cellulitis. They are 
severe infections, and the mortality rates may be as high as 75%. These conditions may be 
characterized by purulent exudates, by varying degrees of tissue necrosis involving the 
skin, fascia, and/or underlying muscles, and sometimes by systemic toxicity and gas 
production. Anaerobic cocci often are isolated with other organisms in these infections. 
They are characteristically found with Staphylococcus aureus and Streptococcus pyogenes 
in progressive bacterial synergistic gangrene, and also are found with gram-negative 
aerobic or facultative bacilli or Bacteroides or both in synergistic non-clostridial 
myonecrosis and synergistic necrotizing cellulites. Diabetes mellitus and vascular 
insufficiency (often associated with trauma) are predisposing factors. Decubitis ulcers and 
postoperative wound infections are other soft-tissue infections from which anaerobic cocci 
have been isolated.  
Anaerobic cocci have been recognized as significant pathogens in puerperal fever and 
septic abortion since the early 1900s. Other infections of the female genital tract in which 
anaerobic cocci have been implicated are pyometra, tubo-ovarian abscesses, postoperative 
wound infections following gynaecologic surgery, and pelvic inflammatory disease, often 
in association with gonococci. 
Peridontal disease, peritonitis, intra abdominal abscesses of the liver, spleen, and pancreas 
are types of intra abdominal infections from which anaerobic cocci have been isolated as 
polymicrobial infections [104]. 
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P. magnus, the most frequent isolated anaerobic coccus, is associated most often with 
chronic bone and joint infections and ankle ulcers. Pure cultures of this organism are not 
rare: they account for 15% of all P. magnus isolates. The presence of foreign bodies, such 
as prosthetic joints, seems to be particularly significant in P. magnus infection.  
 
In one study, anaerobic cocci were isolated in 15 (6%) of 246 cases of mono-microbial 
bacteremia in cancer patients, indicating a relatively rare, but significant pathogenic 
potential for anaerobic cocci in this patient population [104]. Predisposing factors to 
Peptostreptococcal bacteremia include malignancy, recent gastrointestinal, obstetric, or 
gynaecologic surgery; ulceration of the extremities; dental extraction; and 
immunosuppression. 
 
 Peptostreptococcus species are among the most common organisms in anaerobic 
osteomyelitis and arthritis at all sites, including bites and cranial infections. When mixed 
with other aerobes and anaerobes, they may be involved in chronic wounds such as venous 
leg ulcers and severe soft tissue infections such as cellulitis, streptococcal myonecrosis, 
necrotizing fasciitis, and Fournier’s gangrene. P. anaerobius is associated with infections 
of the female genital tract, intra abdominal, polymicrobial soft tissue and dental abscesses. 
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1.6 Diagnosis of anaerobic organisms 
Figure 8: Procedure from collection to identification of anaerobes. 
 
[47] 
 
1.6.1 Collection of specimens 
Specimens collected from sites such as body fluids other than urine, exudates from deep 
abscesses, fine-needle aspirates, and tissue biopsies should be cultured for anaerobic 
bacteria. However, since anaerobes normally inhabit the skin and mucous membranes as 
part of the normal indigenous flora, the specimens are virtually always unacceptable for 
anaerobic culture because the results cannot be interpreted. Gross examination of 
specimens may be valuable in assessing presence of anaerobes. A foul odor, purulent 
appearance of fluid specimens, and the presence of necrotic tissue and gas or sulphur 
granules are all valuable clues. A needle and syringe should be used whenever possible for 
collecting specimens for anaerobic culture. Swabs are not appropriate specimens for 
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isolation of anaerobic organisms. Once the specimens are collected, particular precautions 
should be taken to protect them from oxygen exposure and to deliver them to the 
laboratory promptly [102]. 
 
 Unless the specimen is sent to the laboratory immediately, it should be placed in an 
anaerobic transport tube containing oxygen-free carbon dioxide or nitrogen. The specimen 
is injected through the rubber stopper in the transport tube and remains in the anaerobic 
environment of the tube until processed in the bacteriology laboratory.  
Specimens from sterile sites, such as blood, spinal fluid, or pleural fluid, poses no problem 
provided the usual precautions are taken to decontaminate the skin. 
Specimens should be transported to the laboratory and processed within 2 hours, but kept 
at room temperature if there are delays in processing. Commonly, specimens should not be 
stored for more than 24 hours, biopsy tissue may be maintained for up to 20-24 hours if 
stored at 25° C in an anaerobic transport system. 
 
1.6.2 Selection and use of media for anaerobes 
The primary isolation of obligate anaerobic bacteria from clinical specimens involves the 
use of nonselective, selective, and enrichment media. The choice of media will depend on 
the anatomic source of the specimen. The use of nutritionally adequate media 
supplemented with hemin and vitamin K1 is of key importance. Because abscesses and 
wound infections frequently contain mixtures of obligate anaerobes, facultative anaerobes, 
and aerobes, species present in small numbers are likely to be missed if only nonselective 
media are used.  
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 Most gram-positive bacteria encountered in clinical specimens are inhibited by a 
vancomycin containing media, whereas most gram-negative facultative anaerobes are 
inhibited by an aminoglycoside containing media. 
Egg yolk-neomycin agar may aid in the isolation of Clostridium species from mixed 
microbial populations. The lipase and lecithinase reactions provide useful differential 
characteristics. The medium inhibits various facultatively anaerobic gram-negative bacteria 
but allows the growth of many gram-negative and positive anaerobes, including clostridia 
[7]. 
For susceptibility testing Brucella agar supplemented with 5% blood, 5ug/ml hemin and 1 
ug/ml vitamin K1 is used. This is an enriched, non-selective medium for the isolation and 
cultivation of a wide variety of obligatory anaerobic micro- organisms. It supports the 
growth of fastidious micro- organisms due to its content of peptones, dextrose and yeast 
extract. The sheep blood, hemin and vitamin K1, provide essential nutrients for certain 
obligate anaerobes. The media should be reduced immediately prior to inoculation by 
placing under anaerobic conditions for 18-24 hours [42]. 
 
 
1.6.3 Use of anaerobic systems  
Although several techniques are available for maintaining an oxygen-free environment 
during the processing of specimens for anaerobic culture, the anaerobic jar is the most 
common. It is a medium sized glass or plastic jar with a tightly fitting lid containing 
palladium-coated alumina particles, which serve as a catalyst. It can be set up by two 
methods. The easiest uses a commercially available hydrogen and carbon dioxide generator 
envelope (Gaspak) that is placed in the jar along with the culture plates. The generator is 
activated with water. Oxygen within the jar and the hydrogen that is generated are 
 45
converted to water in the presence of the catalyst, thus producing anaerobic conditions. 
Carbon dioxide, which is also generated, is required for growth by some anaerobes and 
stimulates the growth of others [53]. 
 Anaerobic conditions should always be monitored when using either of the two jar 
techniques by including an oxidation-reduction indicator. Methylene blue strips available 
commercially for this purpose is blue when oxidized and clear when reduced. Thus, if 
anaerobic conditions are achieved, the methylene blue indicator solution will gradually 
turn colorless and will remain that way. If the solution turns blue after being colorless, this 
indicates that anaerobic conditions were not maintained and that the culture results may not 
be valid [102].  
 An alternative method for achieving anaerobiosis in the jar consists of evacuation and 
replacement. Air is evacuated from the sealed jar containing the culture plates and is 
replaced with an oxygen-free mixture of 80% nitrogen, 10% hydrogen, and 10% carbon 
dioxide. 
The anaerobic glove box isolator is an alternative. It is essentially a large clear-vinyl 
chamber, with attached gloves, containing a mixture of 80% nitrogen, 10% hydrogen, and 
10% carbon dioxide. A lock at one end of the chamber is fitted with two hatches, one 
leading to the outside and the other to the inside of the chamber. Specimens are placed in 
the lock, the outside hatch is closed, and the air in the lock is evacuated and replaced with 
the gas mixture. The inside hatch is then opened to introduce the specimen into the 
chamber. Conventional bacteriologic procedures are employed to process the specimen in 
the oxygen-free atmosphere. Although these complex systems are needed to isolate 
anaerobic flora components, studies have shown that the anaerobic jar is adequate to 
recover clinically significant anaerobes. The extremely oxygen-sensitive bacteria of the 
micro flora apparently are not associated with infectious processes [53]. 
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1.6.4 Laboratory identification 
1. Gram stain is used to distinguish between gram- positive and gram- negative 
morphology of bacterial organisms. Crystal violet the primary stain, binds to the 
cell wall after treatment with iodine. Gram- positive organisms have the ability to 
retain the crystal violet after treatment with decolorizer due to the peptidoglycan 
structure of their cell wall and appear violet. Gram- negative bacteria loose the 
crystal violet primary stain when treated with decolorizer, because of the high lipid 
content of their cell wall. These decolorized bacteria then pick up the safranin 
counter-stain and appear red when observed under the microscope. Microscopy is a 
presumptive identification of anaerobic organisms [61]. 
 
Figure 9:  Cell wall structure of gram- positive and negative bacteria 
 
 
 [84] 
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2. Sodium polyanethol sulfonate (SPS) discs- used for the differentiation of 
Peptostreptococci. Specimens are plated out onto 10% blood agar and a SPS disc 
placed on the initial inoculum and incubated anaerobically for 24 hours. The 
organism is SPS susceptible (S) if the zone of inhibition is ≥12mm and SPS 
resistant (R) if the zone of inhibition is ≤ 12mm. 
 
3. Mast identification (MID) 8 rings-for differentiation of anaerobes. The colistin, 
kanamycin, penicillin and vancomycin discs are utilized. A rifampicin disc is 
included for pigmenting gram-negative bacilli. Interpretation of the antibiotic discs: 
sensitive (S) if the zone of inhibition ≥ 10mm and resistant (R) if the zone of 
inhibition ≤10mm. 
 
4. Aesculin agar- is useful in differentiating several species of non-fermenting bacilli. 
Aesculin is a substituted glucoside that can be hydrolyzed by certain bacteria to 
yield glucose and aesculetin.  When aesculin is hydrolyzed the medium turns black 
due to the reaction of aesculetin with the ferric ions in the medium. After touching 
the center of one well-isolated colony with a sterile inoculation loop, inoculate the 
organism onto the surface of the agar and incubate for 18 to 24hrs at 35°C 
anaerobically. Diffuse blackening of more than half of the inoculation within 24 to 
48hrs indicates aesculin hydrolysis. On plates, black haloes should be observed 
around isolated colonies and any blackening is considered positive [61]. 
 
5.  Catalase production. Catalase is an enzyme that decomposes hydrogen peroxide 
(H2O2) into water and oxygen. Hydrogen peroxide forms as one of the oxidative 
end products of aerobic carbohydrate metabolism. A few drops of 3% hydrogen 
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peroxide are placed directly on a colony. Rapid effervescence indicates production 
of molecular oxygen and a positive test. Accurate results may be difficult to obtain 
if the test is performed on colonies growing on blood agar because of the presence 
of peroxidase in erythrocytes [61]. 
 
6. Rapid indole spot test – indole (benzyl pyrrole), is one of the metabolic degradation 
products of the amino acid tryptophan. Bacteria that possess the enzyme 
tryptophanase are capable of hydrolyzing and deaminating tryptophan with the 
production of indole, pyruvic acid, and ammonia. Indole production is an important 
characteristic in the identification of many species of microorganisms. The indole 
test is based on the formation of a red complex when indole reacts with the 
aldehyde group of ρ-dimethylaminobenzaldehyde. This is the active chemical in 
Kovac reagent. A medium rich in tryptophan must be used. Rapid spot tests, using 
filter paper strips impregnated with ρ-dimethylaminocinnamaldehyde reagent, are 
useful in screening for bacteria that are prompt indole producers. A small portion of 
the colony to be tested is transferred from a nonselective medium, such as blood or 
chocolate agar, to a strip of filter paper that has been saturated with Kovac’s 
reagent or ρ-dimethylaminocinnamaldehyde (PACA) solution. The immediate 
development of a red color with Kovac’s reagent indicates the presence of indole 
and a positive test. PACA is more sensitive than Kovac’s reagent, and a positive 
test reaction is indicated by the rapid development of a blue color [61]. 
 
7. Egg yolk agar. This medium is used for lecithinase, lipase and the Nagler reaction. 
Several clostridia produce phospholipases that give rise to a zone of opalescence 
extending beyond the colony or line of growth on human serum or egg-yolk media. 
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Proteolytic colonies produce zones of clearing on this media whilst opalescence 
restricted to the medium underlying a colony and associated with an overlying 
iridescent ‘pearl layer’ indicates lipase activity. The phospholipase reaction 
produced by C. perfringens is specifically neutralized by C. perfringens antitoxin. 
For the presumptive detection of C. perfringens in direct plate culture, prepare and 
dry a plate of good quality digest agar containing egg-yolk 5%. On one half of the 
plate spread 2-3 drops of C. perfringens antitoxin and allow drying. Then seed with 
the test organism or with the exudates under investigation, stroking from the 
antitoxin free to the antitoxin bearing half, and incubate anaerobiclly at 37°C for 
24hrs. On the section containing no antitoxin, C. perfringens colonies show a 
surrounding zone of opacity, i.e. the Nagler reaction, whereas colonies of the 
organism on the remainder of the plate do not [27]. Lecitho-vitellin (LV) is the 
lipoprotein component of egg-yolk and can be obtained as a clear liquid by mixing 
egg-yolk with saline. When lecithinase-forming organisms are grown on a solid 
medium containing LV, the lecithinase diffuses into the agar and produces zones of 
opalescence around individual colonies. Lipolytic organisms also produce 
opalescence on LV agar and are often accompanied by a distinctive pearl layer or 
iridescent film [28]. 
 
8. β-lactamase testing-β-lactamases is heterogeneous bacterial enzymes that cleave 
the β-lactam ring of penicillins and cephalosporins to inactivate the antibiotic. β-
lactamases are found in a wide variety of gram-positive and gram-negative 
bacterial species. The presence of β-lactamases may be detected quickly, providing 
an early clue that an isolate will not respond to the β-lactam antibiotics in question. 
The chromogenic cephalosporin test, employing nitrocefin, is the most sensitive. 
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Filter-paper disks impregnated with nitrocefin are commercially available. A 
loopfull of a colony is smeared on the disk and placed in a closed petri dish to 
prevent rapid desiccation. Organisms that contain β-lactamase will change the color 
of the disk from yellow to red. The reaction usually occurs within 30 seconds, but 
tests are read finally after 15 minutes [61]. 
 
9. Growth on bile agar. The bile test is based on the ability of certain bacteria to grow 
in the presence of bile salts. The medium contains 4% bile salts or 40% bile. With 
an inoculating wire or loop, two or three morphologically similar colonies are 
inoculated on the bile medium and incubated at 35°C for 24-48 hours in an ambient 
incubator. This is then observed for growth or no growth of the organism [61]. 
 
10. Motility nitrate media. Sterilize a solution of potassium nitrate (KNO3) 2% in 
distilled water by autoclaving at 121°C for 20min. Use this to supplement PPY 
medium with KNO3 200µg/ml. To 5ml of the test culture in this PPY nitrate 
medium, add 0.25ml Reagent 1, then 0.25ml Reagent 2. A red color indicates the 
presence of nitrites. Reagent 1 = Addition of 100ml distilled water and 30ml glacial 
acetic acid to 0.5g sulphanilic acid and allow to dissolve. Reagent 2 = Dissolve 
0.2g Cleves acid (5-amino-2 naphthalene sulphonic acid) in 120ml distilled water 
by warming in a water bath, then add 30ml glacial acetic acid [19]. 
 
11. Urease test. Microorganisms that possess the enzyme urease hydrolyze urea, 
releasing ammonia and producing a pink-red color change in the medium. For 
many of these species, a positive urease reaction is first detected by a pink-to-red 
color change in the slant portion of the agar. The slant initially turns red because of 
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the alkaline reaction, resulting from the splitting of small quantities of urea, and is 
augmented by the amines formed from the oxidative decarboxylation of the amino 
acids in the air-exposed portion of the medium. The surface of the agar slant is 
streaked with the test organism and incubated at 35°C for 18-24 hours. Organisms 
that hydrolyze urea rapidly may produce positive reactions within 1 or 2 hours; less 
active species may require 3 or more days. When there is no urea hydrolysis than 
the medium remains the original yellow color [61].  
 
12. Rapid ID 32A Api panels. It is a system used for the identification of anaerobes. 
This strip consists of 32 cupules, 29 of which are used as test cupules and contain 
dehydrated test substrates. After 4 hours of incubation in aerobic conditions, the 
reactions are read visually. Identification is obtained using the identification 
software [12]. The packaged kits test for preformed enzymes. Most of these 
systems use a battery of chromogenic substrates to rapidly test for various amino 
peptidases and glycosidases. Each system requires the preparation of a heavy cell 
suspension from the surface of a purity plate culture. All of the packaged systems 
provide numeric codes, computed databases and identification tables to aid in 
identification once an isolate has been characterized using the system [102]. 
 
13.  Laboratory storage. Isolates can be stored in RCMM (Robertson’s cooked meat 
medium). It is an excellent medium for the growth and maintenance of aerobic and 
anaerobic organisms. Cooked Meat Medium is prepared from heart tissue and has 
the ability to initiate growth of bacteria from very small inoculums and to maintain 
the viability of cultures over long periods of time. The products of growth do not 
rapidly destroy the inoculated organisms and therefore it is an excellent medium for 
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the storage of aerobic and anaerobic bacteria. The addition of glucose in the 
formulation allows rapid, heavy growth of anaerobic bacteria in a short time and 
leads to a more rapid identification of important anaerobes [83].  
 
14. Laboratory sensitivity testing. Susceptibility testing of anaerobes is more 
challenging than aerobes, in part due to their fastidious growth and the need for 
specific diagnostic resources. Agar dilution is cumbersome to set up in a routine 
clinical laboratory for testing of patient isolates. Although the broth microdilution 
may be considered an alternative, up to 40% of clinical strains do not grow in broth 
[23]. Those that grow may do so poorly and thus resistance may potentially be 
underestimated. The CLSI and other expert groups do not recommend disc 
diffusion testing. The varying growth characteristics of different species and within 
species will directly influence zone sizes.  E test uses a predefined and stable 
gradient covering 15 MIC (minimum inhibitory concentration) dilutions. It can be 
readily set up for daily testing and for resistance surveillance of all anaerobes to a 
wide range of antibiotics. It is the only commercial product cleared by the FDA 
(Food and Drug Association) for anaerobes. More than 100 scientific studies and 
publications have validated the reliability of E test for anaerobes. The CLSI 
anaerobe standard acknowledged that a system with a continuous concentration 
gradient, rather than two-fold dilution steps minimizes the uncertainty caused by 
MIC clustering around breakpoints [2]. The MIC is defined as the point on the 
epsilometer scale at which the curve of growth inhibition meets the test strip. Any 
intercept value that falls between two points, on the scale is rounded up to the next 
higher value [88]. However excessively wet plates prior to inoculation, insufficient 
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drying before applying strips and or unevenly streaked surfaces may give non-
confluent growth, jagged edges and uneven MIC intersections [3].  
 
1.7 Mechanisms of resistance among anaerobic bacteria  
Administration of antibiotics, therapeutically or as prophylaxis, causes disturbances in the 
ecological balance between the host and the normal micro-flora. Disturbances in the micro-
flora depend on the properties of the agents as well as of the absorption, route of 
elimination, and possible enzymatic inactivation and/or binding to fecal material of the 
agents. The clinically most common disturbances in the intestinal micro-flora are diarrhea 
and fungal infections that usually cease after the end of treatment. A well-balanced micro-
flora prevents establishment of resistant microbial strains. By using antibiotics that do not 
disturb colonization resistance, the risk of emergence and spread of resistant strains 
between patients and dissemination of resistant determinants between microorganisms is 
reduced. Knowledge of the potential of different antibiotics to cause ecological 
disturbances in the normal micro-flora is of great importance, although individual 
variations of pharmacokinetics, composition, and susceptibility of the normal flora and 
degree of inactivation further determines the ecological outcome of antibacterial therapy 
[74]. 
 
Antibiotic resistance can be explained by two different mechanisms:  
1. Molecular: including recombination or mutation, and 
2. Biochemical: Bacteria that have acquired antibiotic resistance can overcome or 
      avoid the effects of antibiotics through several basic mechanisms namely: 
• Production of -β-lactamases,  
• Loss of outer membrane proteins,  
 54
• Alteration of target site and  
• Expressing active efflux pumps 
          They can possess one or all of these mechanisms simultaneously [51]. 
 
1. Molecular 
Bacterial resistance to antibiotics may develop as a result of a chance mutation or by 
exchange of DNA (deoxyribonucleic acid) with another bacterium. It is known that DNA 
transfer can occur between unrelated species. Plasmids are easily exchanged amongst same 
species, but this is not always the case. Genes that code for antibiotic resistance can be 
contained within these plasmids and transferred between bacteria [18]. Transfer of 
resistance genes has been described for anaerobes in the B. fragilis group and in 
Prevotella, Clostridium, and Fusobacterium species. 
Bacterial conjugation appears to be the preferred method of transfer of antibiotic resistance 
genes. Resistance genes are harbored on transposons, plasmids, and chromosomal 
elements, many of which are mobile. Many of these elements are also small, carrying only 
the necessary genes for initiation of DNA transfer. Physical transfer of the DNA from cell 
to cell requires a mating bridge that appears to be encoded by much larger conjugative 
transposons, which are transferable.  
Bacteroides encode an efficient conjugation system in which multiple, different transfer 
factors use mating-bridge pathways that are inducible. This phenomenon has significant 
implications for the spread of antibiotic resistance genes among organisms in the 
Bacteroides genus, as well as other gut commensals [50].  
The most of β-lactamases produced by Bacteroides spp. are chromosomally mediated and 
produced constitutively. Some contain serine at their active site whereas others, known as 
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metallo-enzymes, require a Zn2+ at their active site for effective β-lactam hydrolysis. 
Although usually chromosomal, plasmid-mediated metallo-β-lactamases does occur. 
Conjugal transfer of clindamycin resistance has been shown to be plasmid-mediated. Many 
of these plasmids are self-transmissible and range in size from 14.6kb to approximately 
82kb. Chromosomally encoded clindamycin resistance is linked to tetracycline resistance 
and the gene has been shown to lie within the tetracycline resistance transfer element. 
The frequency of transfer of resistance to tetracycline is however, very low unless an 
organism is exposed to tetracycline. The tetQ resistance gene is both inducible and 
transferable. Gene transfer occurs by conjugation mediated by the tetracycline resistance 
transfer element itself. Transfer is controlled by a two-component regulatory system. The 
two regulatory genes, rteA and rteB, are located in the tetQ operon downstream from the 
tetQ gene. Their expression is enhanced greatly by the presence of tetracycline, explaining 
the more efficient transfer of genetic material following tetracycline exposure. In addition 
to regulating the movement of the tetracycline resistance transfer element, RteA and RteB 
also are involved in the regulation of transfer of unlinked chromosomal elements called 
non-replicating Bacteroides units (NBU). Although most NBU do not result in any type of 
phenotypic expression, a cefoxitin-hydrolysing β-lactamase gene, cfxA, has been shown to 
reside on a NBU [59]. 
 
2. Biochemical: 
2.1 Resistance against β-lactams 
Some bacteria can synthesize enzymes that destroy the antibacterial agent or modify the 
agent to alter its entry or receptor binding [18].   
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Resistance to β-lactam antibiotics is mediated by 1 of 4 major resistance mechanisms:  
a. Inactivating enzymes (β-lactamases), 
b. Low-affinity, penicillin-binding proteins, 
c. Decreased permeability and 
d. Efflux pumps 
a. Inactivating β-lactamases is the most common and mediates the most diverse 
mechanism of resistance. Enzymes found among Bacteroides and Prevotella spp. 
are functional class 2e cephalosporinases. These enzymes are inhibited by the 
            classical β-lactamase inhibitors: clavulanic acid, sulbactam and tazobactam [50].  
            Zinc metallo-β-lactamases is the most worrisome. These enzymes, encoded by  
            the ccrA or cfiA genes, readily hydrolyze the carbapenems: imipenem, meropenem, 
            ertapenem and other β-lactam agents. These β-lactamases are not 
            inactivated by current β-lactamase inhibitors. It is important to note that as 
            many as 4% of Bacteroides species actually carry the ccrA or cfiA genes, but the 
            genes are not typically expressed to produce enzymes at a sufficiently high level to 
            classify the strains as resistant (<0.8%) [50]. 
 
b.  Low-affinity, penicillin-binding proteins. Some bacteria develop antibiotic 
resistance by altering their cell-wall precursor targets, thereby preventing the 
antibiotic from disrupting the architecture of the cell wall [18]. Penicillin-binding 
proteins (PBP) such as PBP 1 complex and PBP 2, although essential to the activity 
of a β-lactam agent, have not been reported to be major mechanisms of resistance 
development among anaerobes [50]. Binding to PBP is the critical factor in 
determining whether a β-lactam antibiotic will effectively inhibit cell wall synthesis 
in a bacterium. Essential for bacterial growth, PBP function is the terminal stage of 
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cell wall synthesis. When a β-lactam effectively competes for the active site of an 
essential PBP, bacterial cell death results [59]. 
 
c.  Decreased permeability. In addition to enzyme production, permeability changes 
lead to β-lactam resistance among anaerobes. Pore-forming molecules associated 
with decreased permeability and β-lactam resistance has been described. Decreased 
permeability has also been associated with increased β-lactamase production, 
resulting in even higher levels of resistance to β-lactam antibiotics [59]. Pore-
forming proteins of gram-negative anaerobic bacteria include identification and 
cloning of outer-membrane proteins from Bacteroides, Porphyromonas species, 
and Fusobacteria. The absence of ≥1 outer membrane protein has been found to be 
associated with resistance to ampicillin/sulbactam in some strains [50]. A decreased 
uptake or altered membrane permeability affect the ability of the drug to penetrate 
the bacterial cell wall. 
 
d.   Expressing active efflux pumps. Increased elimination of the drug can occur 
through promotion of antibiotic efflux. Antibiotic efflux is an energy-dependent 
process that is related to the generation of an inner membrane protein by the 
resistant bacteria. Alterations that result in the increased expression of these pumps 
can increase the overall capacity of an organism to eliminate a drug, thus enabling 
the organism to resist higher concentrations of that drug [18].     
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1.7.1 Clindamycin resistance 
Resistance to a wide variety of antibiotics may result from alteration of ribosomal binding 
sites. Failure of the antibiotic to binds to its target site(s) on the ribosome disrupts its 
ability to inhibit protein synthesis and cell growth. Alteration of ribosomal target sites is 
the principal mechanism of multiple-agent resistance among aerobic and anaerobic gram-
positive bacteria. There could also be modification of the target enzyme so that it remains 
functional and insensitive to the antibacterial agent, while other bacteria develop resistance 
by over producing target enzymes [18].  
Several genetic clindamycin- resistance determinants have been identified in the B. fragilis 
group of organisms (ermF, ermG, and ermS), Clostridium perfringens (ermQ and ermP), 
C. difficile (ermZ, ermB, and ermBZ), and Porphyromonas, Prevotella, 
Peptostreptococcus, and Eubacterium species (ermF). For both B. fragilis organisms and 
C. difficile, these determinants can be located on the chromosome, plasmids, or 
transposons and are transferable by conjugation. Resistance is mediated by a macrolide-
lincosamide-streptogramin type 23S RNA (ribonucleic acid) methylase. However, not all 
clindamycin-resistant bacteroides poses erm genes, and alternative mechanisms for a 
minority of strains are likely [50]. Among Bacteroides spp., resistance is mediated by 
methylation of 23S rRNA at one of two adenine residues that prevents effective binding of 
clindamycin to the ribosomes, rendering them refractory to the drug’s inhibitory properties. 
This mechanism may be either inducible or expressed constitutively [59]. 
 
1.7.2 Metronidazole resistance 
Metronidazole is a nitroimidazole antibacterial agent that exhibits rapid bactericidal 
activity against some anaerobic organisms such as members of the Bacteroides fragilis 
group [95]. Metronidazole resistance is more common among gram-positive anaerobic 
 59
bacteria, including most isolates of Propionibacterium acnes and Actinomyces species, as 
well as some strains of lactobacilli and anaerobic streptococci. 
 
 The active antibacterial component of metronidazole is stable only under anaerobic 
conditions [50]. Resistance to metronidazole is attributed to a combination of reduced 
nitroreductase and decreased drug uptake by the organism. Both of these occur 
simultaneously [59]. 
 Metronidazole activity is dependent on the reduction of the nitro group to form a reactive 
intermediate product [1]. Nitroimidazole resistance genes (nim) encode a nitroimidazole 
reductase, which reduces 4or 5- nitroimidazole to 4 or 5- aminomidazole and prevents the 
formation of toxic nitrosoresidues necessary for the agent’s activity. Six related 
chromosomal or plasmid-based nim genes (nim A-F) have now been reported in 
Bacteroides species. Insertion sequence elements, either identical or similar to those found 
in imipenem-resistant strains, are also found upstream of the nim genes, likely increasing 
their expression [50]. 
 The entry of 5-nitroimidazoles into the cell depends on the rate of reduction of the nitro 
group. A decrease in the reducing environment within the bacterium will result in reduced 
nitroreductase activity and a concomitant reduction in drug uptake. Decreased pyruvate: 
ferredoxin oxireductase activity in combination with a compensatory increase in the lactate 
dehydrogenase activity results in a decrease in the reducing power of the bacterium [59].  
Thus the in-vitro activity of metronidazole necessitates an immediate reduction of the drug 
at a low redox potential of at least Eh-450 mV to promote a continued uptake of the drug 
as the organism grows [1].   
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Two genes, designated nimA and nimB, capable of conferring moderate to high-level 
resistance have been described. DNA sequencing of these two genes shows approximately 
73% similarity, and they presumably represent two unique genes that confer resistance by 
the same mechanism. These genes have been localized to the chromosome as well as to a 
variety of different non-self-transmissible plasmids. These plasmids can, however, be 
mobilized by other conjugal elements or acquired by transformation [59]. 
 
1.7.3 Quinolone resistance 
Whether the typically low rate of susceptibility to most quinolones is due to poor drug 
penetration, low affinity for the target topoisomerases II and IV, or some other mechanism 
has not yet been clearly ascertained. Concomitant reduced cell permeability has, however, 
been described in clinical isolates of B. fragilis to cefoxitin and norfloxacin. Quinolones 
are generally bacteriostatic rather than bacteriocidal under anaerobic conditions [59]. 
 
In both aerobic and facultatively anaerobic bacteria, fluoroquinolones inhibit DNA gyrase 
and topoisomerase IV, both of which are essential for bacterial DNA replication. 
Resistance in aerobes occurs by mutations in gyrase (gyrA) and topoisomerase IV (parC) 
genes and/or by increased expression of efflux pumps. Similar mechanisms have been 
discovered in anaerobic bacteria. In B. fragilis, both gyrA and gyrB were cloned from the 
bacteroides genome [50]. 
 
1.7.4 Tetracycline resistance 
Protection or modification of the target site is the only documented mechanism of 
resistance to tetracycline in Bacteroides spp. The chromosomal tetQ gene encodes a 
protein that renders the ribosomal protein synthesis apparatus refractory to the inhibitory 
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effects of tetracyclines. DNA cross-hybridization studies indicate that a tetQ or tetQ-like 
gene is present in most tetracycline-resistant Bacteroides isolates. Identification of 
tetracycline-resistant isolates that do not contain tetQ DNA sequences indicates that 
another mechanism (e.g. efflux of tetracycline) or another class of ribosomal protection 
proteins also contributes to tetracycline resistance. 
 Tetracycline resistance genes have also been identified in Costridium spp. The tetA (P) 
and tetB (P) genes together form an operon encoding two unrelated proteins that result in 
tetracycline resistance mediated by two separate mechanisms.  The tet gene product 
inactivates tetracycline by oxidation of the molecule, but is active only under aerobic 
conditions and has, therefore, not been shown to be operational in Bacteroides spp [59].  
 
1.7.5 Chloramphenicol resistance 
 
Two different classes of chloramphenicol resistance genes have been reported in 
Bacteroides spp. Both result in drug inactivation either through acetylation or by nitro-
reduction at the ρ-nitro group of the benzene ring. The chloramphenicol acetyltransferase 
gene is transferable and plasmid-mediated [59]. 
 
1.7.6 Aminoglycoside resistance 
 
It appears as if aminoglycoside resistance is the result of the drugs failure to reach their 
target sites. Aminoglycoside uptake is a two-step process involving both energy-
independent and energy-dependent phases. Either oxygen or a nitrogen-dependent electron 
transport system has the capability to provide the energy necessary for the energy-driven 
phase of aminoglycoside uptake. Strict anaerobes lack these electron transport systems and 
are therefore impermeable to aminoglycosides [59]. 
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1.8 Management 
1.8.1 Surgical 
In addition to antimicrobial therapy, surgical drainage of abscesses, excisions of necrotic 
tissue, relief of obstruction, and ligation or re-section of infected veins are important. 
 Percutaneous non-surgical drainage may be effective in certain patients. Lung abscess, 
which responds well to medical therapy, is the primary exception to the rule that abscesses 
require surgical drainage [38]. 
Treatment of gas gangrene includes radical surgical debridement coupled with high doses 
of antibiotics. Successful treatment of, less severe forms of clostridial wound infections 
includes local debridement and antibiotic therapy. The usefulness of gas gangrene antitoxin 
is a disputed matter. Some physicians maintain that the efficacy of this polyvalent antitoxin 
has been proved in the past, but better medical care now may have eliminated the need for 
its use. Others believe that because of insufficient data, antitoxin should be administered 
systemically as early as possible after diagnosis, and that the antitoxin should be injected 
locally into tissue that cannot be excised [105]. 
 
1.8.2 Prevention 
There are two approaches in preventing anaerobic infections:  
i. Avoiding conditions that reduce the redox potential of the tissues and  
ii. Preventing the introduction of anaerobes of the normal flora to wounds, closed 
cavities, or other sites prone to infection. 
 
Minimizing injury and devitalization of tissue during surgery protects against infection. 
The use of closed methods of bowel resection, when feasible, decreases the likelihood of 
infection with members of the bowel flora. Appropriate therapy of established infections 
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such as chronic otitis media and sinusitis may prevent subsequent spread of infection such 
as intra-cranial abscess. Precautions to minimize aspiration are helpful in preventing 
anaerobic pulmonary infection [38]. 
  
Prevention of wound contamination is the single most important factor in controlling 
clostridial wound infections. In the past, immunization has been considered a possible 
preventive measure for gas gangrene; however, several factors have discouraged the use of 
active immunization, including difficulty in preparing a suitable antigenic toxoid, 
availability of prompt wound treatment, and accessibility of effective therapeutic agents 
[105]. 
 
 Prophylactic antimicrobial therapy is effective in selected situations:  
 Patients with acute leukemia on treatment with anti-tumor chemotherapy may 
require administration of an antimicrobial regimen designed to reduce the total 
body flora, including anaerobes. 
  Anaerobic bacteremia following dental manipulation may be managed effectively 
by administration of an antibacterial agent 1 hour before manipulation. 
  The effectiveness of prophylactic antimicrobial therapy before bowel surgery is 
now well established, as well as gynaecologic surgery [38].  
  
A series of 4 primary immunizations against tetanus, followed by boosters q 10 yr, with the 
adsorbed (for primary immunization) or fluid (for boosters) toxoid is superior to giving 
antitoxin at the time of injury. Immunization in an unimmunized or inadequately 
immunized pregnant woman produces both active and passive immunity in the foetus and 
should be given at a gestational age of 5 to 6 months with a booster at 8 months [69].  
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Proper canning and adequate heating of home-canned food before serving are essential. 
Canned foods showing evidence of spoilage and swollen or leaking cans should be 
discarded. Infants < 12 months should not be fed honey, which may contain C. botulinum 
spores. Toxoids are available for active immunization of people working with C. 
botulinum or its toxins. 
 Although anaerobic infections can occur in any individual, good hygiene and general 
health management may help to prevent infections [69]. 
 
1.8.3 Antimicrobial administration 
Since anaerobic infections are generally polymicrobial, where anaerobes are mixed with 
aerobic organisms, therapy should provide coverage of both types of pathogens. Treatment 
of anaerobic infections is also complicated by the slow growth of these organisms. The 
primary role of antimicrobials is to limit the local and systemic spread of infection [58]. 
Patients with nosocomially-acquired, intraabdominal infections are more likely to grow 
resistant pathogens. Inadequate empiric antimicrobial therapy is associated with treatment 
failure and death. Therefore, broader spectrum antimicrobial regimens are recommended 
for these patients [68].  
 
Presently the drugs of choice for anaerobic gram- negative bacilli at Charlotte Maxeke 
Johannesburg Academic Hospital include amoxicillin- clavulanate, cefuroxime, 
metronidazole and alternate drugs include cefuroxime plus clindamycin or ertapenem. 
Lung abscess and necrotizing pneumonia may be caused by anaerobes of the oral cavity. In 
a comparative trial performed by Levison M.E et al., it was found that clindamycin to be 
clearly more effective than penicillin. A randomized study performed by Ferna’ndez-Sabe’ 
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et al demonstrated that penicillin failures were associated with penicillin-resistant 
Prevotella melaninogenica. 
 Following these results most authorities recommend clindamycin as the drug of choice for 
the initial therapy of anaerobic lung infections. In the same study performed by 
Ferna’ndez-Sabe’ all anaerobes and most facultative organisms isolated from respiratory 
samples have been susceptible to amoxicillin-clavulanate indicating that amoxicillin-
clavulanate is a good therapy for patients with severe, community-acquired anaerobic lung 
infections, defined as lung abscess or necrotizing pneumonia. Amoxicillin-clavulanate 
provides coverage against the pathogens that are most likely to be involved in these 
infections, and it is effective in resolving the clinical signs and symptoms of the disease. 
  
Both duration of fever and putrid sputum production were shorter in these patients treated 
with amoxicillin-clavulanate than in previously studied patients receiving clindamycin. An 
additional advantage, as in the case of clindamycin, is the possibility of using sequential 
therapy, beginning with intravenous administration for a few days and then switching to 
the oral route with the same antibiotic [37]. 
   
Clinicians should be aware that in vitro antimicrobial susceptibility tests have shown that 
some strains of anaerobic cocci are resistant to penicillin or to clindamycin. Metronidazole 
is typically active against most strains of anaerobic cocci [104]. Although Penicillin G is 
the drug of choice for treating infections involving anaerobic cocci, alternate choices 
would be a cephalosporin, clindamycin or chloramphenicol. 
Penicillin is the drug of choice for all clostridial wound infections [105].  
Trivalent antitoxin (A, B, E) is available for botulinism. Antitoxin does not inactivate toxin 
that is already bound at the neuromuscular junction; therefore, pre-existing neurologic 
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impairment cannot be reversed rapidly. However, antitoxin may slow or halt further 
progression. Antitoxin should be given as soon as possible after clinical diagnosis. 
Antitoxin is less likely to be of benefit if given > 72 hours after symptom onset [69]. 
Tetanus therapy requires maintaining adequate ventilation. Additional interventions 
include early and adequate use of human immune globulin to neutralize nonfixed toxin; 
prevention of further toxin production; sedation; control of muscle spasm, hypertonicity, 
fluid balance, and intercurrent infection; and continuous nursing care. If necessary, 
immune globulin or antitoxin can be injected directly into the wound, but this injection is 
not as important as proper wound care. Following injury, tetanus vaccination is given 
depending on wound type and vaccination history; tetanus immune globulin may also be 
indicated. Patients not previously vaccinated are given 2nd and 3rd dose of toxoid at 
monthly intervals [69]. 
 Due to the mixed nature of the infection and the presence of granules successful treatment 
of actinomycosis requires long-term antibiotic therapy combined with surgical drainage of 
the lesions and excision of damaged tissue. Actinomyces spp. and P. propionicus are 
susceptible to penicillins, the cephalosporins, tetracycline, chloramphenicol, and a variety 
of other antibiotics. Penicillin is the drug of choice for infections with all species of 
Actinomyces; significant drug resistance is unknown [16].  
 
Organisms to be considered for antimicrobial susceptibility testing because of their 
virulence, or because they are commonly resistant to certain antimicrobial agents include 
species of the Bacteroides fragilis group, species of the pigmented Prevotella-
Porphyromonas group, other Prevotella, Fusobacterium mortiferum, F. varium, and F. 
necrophorum, Bilophilia, Sutterrella, and some Clostridium species [102]. 
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2.0 Rationale for study 
2.1 Projected Outcome 
This study will provide information to the clinician about susceptibility to the 
antimicrobial agents of anaerobic bacteria from patients admitted at Charlotte Maxeke 
Johannesburg Academic Hospital. Antimicrobial resistance patterns have changed lately 
worldwide and this information will be used to create antimicrobial guidelines for 
empirical treatment of anaerobic infections in the local area. 
The study will initiate and provide a foundation for a surveillance program for 
anaerobic organisms at the Microbiology Laboratory of the Charlotte Maxeke 
Johannesburg Academic Hospital, and finally, the data will be used to monitor the 
prevalence of antimicrobial resistance from a public health perspective. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 68
3.0  
3.1 Aim 
This study aimed to determine the antimicrobial susceptibility patterns of anaerobic     
organisms isolated from clinical specimens and to analyze demographic data of 
patients admitted at Charlotte Maxeke Johannesburg Academic Hospital. 
 
 
3.2 Objective 
To initiate and organize this survey such that it can be performed on a regular periodic 
basis to update the data and identify changing trends in susceptibility and resistance. 
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4.0 Materials and methods  
All anaerobes used for this study were routinely isolated from clinical specimens. After 
they were isolated and identified they were stored in RCMM until sensitivity was 
performed.  The sensitivity testing was performed for purpose of this study in batches 
where each batch comprised of nine anaerobes including the reference strain controls. 
  
4.1   Microscopy, identification and sensitivity  
4.1.1 Microscopy 
On all isolates gram-stain was performed. 
Method: 
i. A thin smear of the organism was made and allowed to air dry after which it 
was fixed using methanol or heat. 
ii.  The slide together with a control slide was stained. The control slide 
consisted of E. coli as the negative control and S. aureus as the positive 
control.  First it was stained with crystal violet for approximately one 
minute and then washed with tap water. 
iii.  Next it was stained with gram’s iodine for approximately one minute and 
washed with tap water. 
iv.  Thereafter it was decolorized with gram’s decolorizer for only 10 seconds 
or less and washed with tap water. 
v.  Lastly it was stained with safranin for approximately 30 seconds and 
washed with tap water. 
vi. The slides were allowed to air dry before examination under 100x oil 
immersion objective. 
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vii.  Ensuring that the control slides are correct, gram-positive organisms 
stained violet and gram-negative organisms stained pink in color. 
 
4.1.2 Identification 
All isolates were primarily cultured on basic 10% blood agar and amikacin agar plates. 
For the identification of anaerobes, the Finegold System was implemented incorporating 
the following aspects: 
 
4.1.2.1 Gram-positive cocci 
 Except for Peptococcus niger all former species of the genus Peptococcus were 
transferred to the genus Peptostreptococcus. The organisms were plated out on a 10% 
blood agar plate with a SPS disc and incubated in an anaerobic jar at 37°C for 24-48 hours. 
If the organism was SPS susceptible then it was reported as Peptostreptococcus anaerobius 
and if the organism was SPS resistant it was reported as Peptostreptoccus species. 
 
4.1.2.2 Gram-positive bacilli 
Anaerobic gram-positive bacilli of human clinical relevance are divided into two distinct 
groups, one genus of endospore formers (Clostridium species) and genera of non-spore-
formers. 
 
4.1.2.2.1 Gram-positive spore forming bacilli (Figure 10) 
Certain clostridia for example: C. tertium, C. inulinum, C. durum and C. carnis are aero-
tolerant and form colonies on chocolate agar incubated in 5% to 10% carbon dioxide (i.e. 
in micro-aerophilic conditions). The following criteria are used to determine whether an 
isolate is an aero-tolerant clostridia species or a facultatively anaerobic Bacillus species. 
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Aero-tolerant clostridia will rarely form spores when grown aerobically and are catalase 
negative, whereas Bacillus species will rarely form spores when grown anaerobically and 
are catalase positive. To demonstrate spores, gram-stained preparations are usually 
sufficient. 
 
Figure 10: Identification of gram-positive spore forming bacilli 
 
 
 
 
 
 
Clostridium perfringens                                Clostridium species to be further identified           
Clostridium sordelli 
Clostridium bifermentans 
 
      4.1.2.2.2 Gram-positive non-spore forming bacilli (Figure 11) 
Included in this group are members of the following genera: 
Branching bacteria:  Actinomyces and Bifidobacterium 
Non-branching bacteria:  Propionibacterium and Eubacterium 
 
Organisms were plated out on 10% blood agar for rapid indole. An aesculin plate was 
inoculated for aesculin hydrolysis and catalase and a nitrate medium was also 
inoculated. Incubation was 37°C for 24-48 hours in an anaerobic jar. 
 
Gram- positive spore forming bacilli 
Nagler positive Nagler negative 
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Figure 11: Identification of gram-positive non-spore forming bacilli  
 
 
 
 
 
 
  
 
 
 
 
 
4.1.2.3 Gram-negative cocci 
A motility nitrate medium was inoculated and incubated anaerobically in a jar at 37°C 
for 24 hours. A pink color indicates a positive reaction and was reported as Veillonella 
parvula. A negative result indicated by a yellow color was reported as an anaerobic 
gram-negative coccus. 
 
4.1.2.4 Gram-negative bacilli 
These species are identified on the basis of colonial and cellular morphology, pigment 
production, susceptibility to antibiotic discs and certain rapid biochemical 
characteristics: 
 
 
Non-spore formers 
Spot indole 
Positive Negative 
Propionibacterium 
species 
 
Nitrate reduction 
Negative Positive 
Bifidobacterium 
Eubacterium 
Coccobacilli Branching rods 
Eubacterium species Actinomyces species 
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1. B. urealyticus- presumptively identified by showing “pitting” growth. 
2. Prevotella species are saccharolytic and produce a black pigment due to proto-heme  
     production. 
3. Porphyromonas species are asaccharolytic and also produce a black pigment. 
 
A 10% blood agar plate was inoculated and a MAST MID8 ring placed in the center of 
the plate. An aesculin agar, basal agar and egg yoke for anaerobes was also inoculated. 
If the organism showed pitting growth a urea slope was added. All plates were 
incubated anaerobically in a jar for 24-48 hours at 37°C. 
 
Table 1: Antibiotic discs used for identification of anaerobic gram-negative bacilli  
Table 2: Identification tests used for the Bacteroides group 
Table 3: Identification tests used for Fusobacteria and Prevotella species 
Table 4: The cellular morphology characteristics of Fusobacteria 
 
 Table1. Antibiotic discs used for identification of anaerobic gram-negative bacilli.  
Anaerobic organisms Colistin 
(10µg) 
Kanamycin 
(1000µg) 
Vancomycin 
(5µg) 
Penicillin 
(2 units) 
Rifampicin 
(15µg) 
Bacteroides 
fragilis 
R R R   
Bacteroides  
urealyticus 
S S R   
Prevotella  
species 
S R R R S 
Prevotella 
intermedia 
S R R S/R S 
Porphyromonas 
species 
S R R S S 
Fusobacterium 
species 
S S R   
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Table 2 Identification tests used for the Bacteroides group 
 Aesculin 
hydrolysis 
Indole 
spot 
test 
Catalase Bile agar Urease 
Bacteroides 
fragilis 
Positive Negative Positive Growth  
Bacteroides  
thetaiotaomicron 
Positive Positive Positive Growth  
Bacteroides  
ovatus 
Positive Positive Negative Growth  
Bacteroides  
vulgatus 
Variable Negative Negative Growth  
Bacteroides 
urealyticus 
Negative Negative Negative Inhibited Positive 
 
 
 
Table 3 Identification tests used for Fusobacteria and Prevotella 
 Aesculin 
hydrolysis 
Indole spot 
test 
Catalase Bile agar Lipase 
Prevotella 
species 
Positive Negative Negative Inhibited  
Prevotella 
intermedia 
Negative Positive Negative Inhibited  Positive 
Porphyromonas 
species 
Negative Positive Negative Inhibited  
Fusobacterium 
nucleatum 
Negative Positive Negative Inhibited  
Fusobacterium 
mortiferum 
Positive Negative Negative Growth  
Fusobacterium 
necrophorum 
Negative Positive Negative Inhibited Positive 
Fusobacterium 
varium 
Negative Variable Negative Growth  
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Table 4 Cellular morphology characteristics of the Fusobacteria 
Species Distinctive cellular morphology 
Fusobacterium nucleatum Slender with pointed ends 
Fusobacterium mortiferum Bizarre round bodies 
Fusobacterium necrophorum Large and pleomorphic 
Fusobacterium varium Pleomorphic 
 
The following Fusobacterium species may produce hydrogen sulphide (This is seen by 
blackening of the colonies on aesculin agar): Fusobacterium mortiferum, Fusobacterium 
necrophorum and Fusobacterium varium. 
 
Fusobacterium necrophorum subspecies necrophorum is lipase positive whereas 
Fusobacterium necrophorum subspecies funduliforme is lipase negative. 
A new species, Fusobacterium ulcerans isolated from tropical ulcers, closely resembles 
Fusobacterium mortiferum but is aesculin negative. 
 
Although Bilophila wadsworthia is similar to species of the B. fragilis group, and to certain 
Fusobacterium species that grow in the presence of 20% bile several of the phenotypic 
properties of Bilophila wadsworthia are different from those of the B. fragilis group and 
Fusobacterium species. Bilophila wadsworthia differs from the B. fragilis group by its 
failure to ferment carbohydrates, its production of urease, and its failure to produce a major 
amount of succinic acid. The production of strong catalase activity and its lack of butyric 
acid production are key characteristics that separate B. wadsworthia from Fusobacterium 
species [102]. 
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Figure 12: Flowchart of the identification of gram-negative anaerobic bacilli. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Km = Kanamycin 
 
 
 
Km = Kanamycin, Vm = Vancomycin, S = Sensitive, R = Resistant.  
 
 
 
Growth in the presence of 20% bile 
No Yes 
Km R 
Vm S 
Km s 
Vm R 
Km R 
Vm R 
Km S 
Vm R 
Porphyromonas 
 species 
Pigmentation 
No Yes 
Prevotella spp. Urease 
Positive Negative 
Bacteroides 
ureolyticus 
- pitting agar 
- catalase 
positive 
 
Spot indole 
Positive Negative 
Fusobacterium spp. Fusobacterium nucleatum 
- Uniform with tapering 
ends 
Fusobacterium necrophorum 
- Pleomorphic with 
rounded ends  
Fusobacterium 
mortiferum/ 
varium 
Bacteroides fragilis 
group 
Spot indole 
Positive Negative 
B. thetaiotamicron 
B. uniformis 
B. ovatus 
 
B. fragilis 
B. vulgatus 
B. disastonis 
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When anaerobes were not successfully identified using the Finegold system than they were 
tested using the rapid ID 32A Api panels.  
 
4.1.3 Sensitivity 
4.1.3.1 Materials used 
  Mueller-Hinton broth for inoculum preparation.  
  1 McFarland standard  
 E test strips, storage tubes, package insert, E test technical guides and CLSI 
guidelines. The following antimicrobial agents were tested (Table 5) and 
interpreted following CLSI guidelines (Table 6).  
 Brucella agar plates with a depth of 4-5mm 
 
Table 5: Antimicrobial agents tested 
Antibiotic Concentration of E test 
Clindamycin 0.016-256µg/ml 
Metronidazole 0.016-256µg/ml 
Chloramphenicol 0.016-256µg/ml 
Ertapenem 0.002-32µg/ml 
Cefoxitin 0.016-256µg/ml 
Piperacillin/tazobactam 0.016-256µg/ml 
Benzylpenicillin 0.002-32µg/ml or 
0.016-256µg/ml 
Amoxicillin/clavulanic acid 0.016-256µg/ml 
Ceftriaxone 0.002-32µg/ml or 
0.016-256µg/ml 
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Table 6 CLSI antimicrobial breakpoints for susceptibility testing for anaerobic organisms 
Antibiotic Abbreviation Susceptible  
Break-point 
(µg/ml) 
Intermediate 
Break-point 
(µg/ml) 
Resistant 
Break-
point 
(µg/ml) 
Amox/clavulanic Xl 
   ≤   4          8    ≥   16 
Penicillin Pg 
   ≤   0.5          1    ≥    2 
Cefoxitin Fx 
   ≤  16         32    ≥   64 
Ceftriaxone Tx 
   ≤  16         32    ≥   64 
Chloramphenicol Cl 
   ≤   8         16    ≥   32 
Clindamycin Cm 
   ≤   2          4    ≥    8 
Ertapenem Etp 
   ≤   4          8    ≥   16 
Metronidazole Mz 
   ≤   8         16    ≥   32 
Pip/tazobactam Ptc 
   ≤  32         64    ≥   128 
 
 
 
4.1.3.2 Method  
 The E test storage tubes was removed from the freezer and allowed to reach room 
temperature for approximately 30 minutes. 
1. Depending on the growth of the strain, individual viable colonies from a 24, 48  
    or 72 hour agar plate were suspended in Mueller-Hinton broth and mixed carefully 
    minimizing aeration. The turbidity was adjusted to a 1 McFarland standard. 
2. Ensuring that the agar surface was dry before swabbing, a sterile swab was seeded  
    into the inoculum, excess fluid removed and the entire surface of the brucella plate 
    swabbed evenly in three directions. 
3. The surface of the plate was allowed to dry for 10 minutes. 
4. The E test strips were applied to the surface of the agar with forceps and once applied 
    the strip was not moved. 
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5. The plates were incubated immediately in an anaerobic jar for 24, 48 hours, or 
    longer for slow growers. 
6. The isolates were stored in Robertson’s Cooked Meat Medium.  
 
4.2 Quality control 
Quality control was performed with organisms of known susceptibility. Separate 
plates of these organisms were tested with the same E test strips under the same 
conditions with each batch. Control strains that were used:  
 Bacteroides fragilis ATCC 25285 
 Bacteroides thetaiotaomicron ATCC 29741 
 Eubacterium lentum ATCC 43055 
 
 4.3 Reading 
       MIC interpretation was performed using CLSI guidelines. The MIC was 
      defined as the lowest concentration of each antimicrobial that inhibited the visible 
      growth including hazes and isolated colonies of the test isolate. The MIC was read  
      after 24 to 48 hours, if sufficient growth was obtained and the ellipse was clearly 
      visible. The clindamycin results were confirmed after 48 hours due to inducible  
      resistance [1]. For the slow growers the MIC was read after 48-72 hours. When  
      growth was inadequate or the inoculum too light, the test was repeated or eliminated. 
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5.0 Results 
A total number of 180 anaerobes from 165 different patients were tested. Multiple samples 
from a single patient that grew the same organism (even at different intervals or from 
different anatomical sites) were only done once hence all the isolates are non-repetitive.  
There were 14 patient samples that cultured more than one anaerobe. Patient demographics 
are seen in figure 13. 
 
Figure 13. Patient demographics 
 
 
 
 
 
 
 
 
 
Total number of 26 patients provisionally diagnosed by the attending physician with sepsis 
is characterized in the figure 14. 
Total patients 165 
Total adults 139 Total children <12yrs = 18 Unknown 8 
Males = 99 
Females = 66 
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Septic limb/foot
69%
Blood sepsis
12%
Gynaecological 
sepsis
19%
Figure 14. Identified sources of sepsis in 
26 patients provisionaly  diagnosed   
 
Admission of the patients to various wards is presented in the figure 15. 
 
Figure 15. Patient admissions at different wards in CMJAH. 
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 82
The type of specimens is listed in table 7. 
 
Table 7. Type of specimens 
Type Total number 
Abdominal fluid  3 
Abscess  7 
Abdominal abscess  4 
Aspirate  3 
Blood cultures  27 
Bone  3 
Breast  3 
Drain fluid  2 
Empyema  1 
Fluids  36 
Other  4 
Placenta  1 
Pleural fluid  2 
Pus   41 
Tissue  34 
Umbilicus  1 
Unknown  8 
 
 
 
In view of isolation rates from all infection sources see figure 16. 
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Figure 16. Percentage of anaerobic species from 180 isolates   
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Routinely pus swabs are not cultured for anaerobes at the microbiology laboratory at 
CMJAH, unless they are transported in appropriate anaerobic transport media. None of the 
isolates in this study were isolated from a pus swab. 
 
Analysis of the types of specimens from which the larger group of organisms originated is 
illustrated in figure 17 and 18. 
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Figure 17. Sources of Bacteroides group 
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Figure 18. Sources for Clostridium group. 
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Susceptibility testing of nine antibiotics was performed on 180 isolates; penicillin 
demonstrated the highest resistance of 66.7%, followed with clindamycin 13.9%, 
metronidazole (8.9%), ceftriaxone (8.3%), cefoxitin (7.2%), amox/clavulanic acid (2.8%), 
ertapenem (1.1%), piperacillin/tazobactam (0.6%) and no resistance to chloramphenicol. 
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The study indicates the most active agents were: chloramphenicol with susceptibility of 
100% followed with piperacillin/tazobactam (99.4%), ertapenem (97.2%), 
amoxicillin/clavulanic acid (96.7%), while metronidazole demonstrated 89.4% 
susceptibility, cefoxitin (85%), clindamycin (81.7%), and ceftriaxone (68.3%) and as 
expected penicillin exhibited poor susceptibility (33.3%). 
 
Figure 19. Susceptibility testing results of 180 anaerobic organisms 
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However intermediate sensitivity was seen in ceftriaxone, cefoxitin, clindamycin, 
ertapenem, metronidazole and amoxicillin/clavulanic acid being 23.3%, 7.8%, 4.4%, 1.7%, 
1.7% and 0.6% respectively to all the 180 tested anaerobes (Figure 20).  
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Figure 20. Intermediate susceptibility results of 180 anaerobic organisms 
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The MIC50 and MIC90 of all isolates to the nine antibiotics are illustrated in Table 8. 
 
Table 8. The MIC50 and MIC90 of all isolates  
Antibiotic MIC50 MIC90 MIC Range 
Amoxicillin/Clavulanic acid 0.19 µg/ml 1 µg/ml 0.016-96 µg/ml 
Cefoxitin 3 µg/ml 32 µg/ml 0.016-256 µg/ml 
Ceftriaxone 3 µg/ml 32 µg/ml 0.002-256 µg/ml 
Chloramphenicol 1 µg/ml 2 µg/ml 0.016-8 µg/ml 
Clindamycin 0.19 µg/ml 256 µg/ml 0.016-256 µg/ml 
Ertapenem 0.125 µg/ml 1.5 µg/ml 0.002-32 µg/ml 
Metronidazole 0.5 µg/ml 16 µg/ml 0.016-256 µg/ml 
Penicillin G 12 µg/ml 32 µg/ml 0.002-256 µg/ml 
Piperacillin/Tazobactam 0.19 µg/ml 4 µg/ml 0.016-256 µg/ml 
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From 180 isolates tested, 97 organisms belong to the Bacteroides group:  Bacteroides 
fragilis (81), Bacteroides thetaiotaomicron (4), Bacteroides vulgatus (3), Bacteroides 
ovatus (5), Bacteroides species (1), Bacteroides uniformis (1), Bacteroides distasonis (1), 
and Bacteroides eggerthii (1) figure 21. 
 
Figure 21. Composition of the Bacteroides group 
C ompos ition of the B acteroides  g roup
81
4 3 5 1 1 1 1
0
10
20
30
40
50
60
70
80
90
B. fragilis
B. thetiotaom
icron
B. vulgatus
B. ovatus
B. species
B. uniform
is
B. distasonis
B. eggerthii
 
 
This group of anaerobic organisms presented with highest susceptibility (100%) to 
piperacillin/tazobactam, amoxicillin/clavulanate, chloramphenical, to ertapenem (94.8%), 
lesser to metronidazole (86.6%) and low down to both clindamycin and cefoxitin (75.3%) 
Figure 22. 
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Figure 22. Susceptibility testing results of the Bacteroides group 
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Intermediate activity of the Bacteroides group has been seen in this study. 
From the 97 isolates 29.9% were intermediately sensitive to ceftriaxone, 14.4% to 
cefoxitin, 6.2% to clindamycin, 3.1% to ertapenem and 2.1% to metronidazole, Figure 23. 
 
Figure 23. Intermediate sensitivity of the Bacteroides group 
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The MIC 50 and MIC 90 of the Bacteroides group are illustrated in Table 9. 
 
  Table 9. The MIC 50 and MIC 90 of the Bacteroides group 
Antibiotic MIC 50 MIC 90 MIC Range 
Amoxicillin/Clavulanic acid 0.25 µg/ml 1.5 µg/ml 0.023-3 µg/ml 
Cefoxitin 8 µg/ml 48 µg/ml 0.125-256 µg/ml 
Ceftriaxone 8 µg/ml 256 µg/ml 0.008-256 µg/ml 
Chloramphenicol 1 µg/ml 2 µg/ml 0.094-3 µg/ml 
Clindamycin 0.5 µg/ml 256 µg/ml 0.016-256 µg/ml 
Ertapenem 0.25 µg/ml 3 µg/ml 0.002-32 µg/ml 
Metronidazole 0.5 µg/ml 128 µg/ml 0.023-256 µg/ml 
Penicillin G 32 µg/ml 256 µg/ml 0.064-256 µg/ml 
Piperacillin/Tazobactam 0.25 µg/ml 6 µg/ml 0.016-32 µg/ml 
 
 
The most active antimicrobials to Bacteroides fragilis in this study have been observed 
with amoxicillin/clavulanic acid, chloramphenicol and piperacillin/tazobactam to which all 
the isolates were 100% sensitive. Excellent sensitivity was also seen in ertapenem and 
metronidazole being 93.8% and 85.2% respectively (Figure 24). 
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Figure 24. Susceptibility testing results of the 81 isolates of Bacteroides fragilis 
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The highest antimicrobial resistance with this organism is seen with penicillin (97.5%), 
(Bacteroides spp. usually produce β-lactamases that confer resistance to penicillin), 
followed by clindamycin (14.8%), metronidazole and ceftriaxone both (12.3%), cefoxitin 
(8.6%) and ertapenem (2.5%). 
 
A number of 23 Clostridium perfringens isolates was tested, which demonstrated excellent 
sensitivity to all the antimicrobials agents except lesser susceptibility to clindamycin (87%) 
Figure 25 
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Figure 25. Susceptibility testing results of the 23 Clostridium perfringens isolates 
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From the 23 isolates of Clostridium perfringens, 4.3% were resistant to clindamycin and 
8.7% intermediately sensitive (Figure 26). 
 
Figure 26. Distribution of sensitivity of Clostridium perfringens with clindamycin 
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Overall 20 isolates of Peptostreptococcus species including: Peptostreptococcus 
anaerobius (15), Peptostreptococcus spp (2), Peptostreptococcus prevotti (1), 
Peptostreptococcus asaccharolyticus (1), and Peptostreptococcus magnus (1), 
demonstrated 100% sensitivity to cefoxitin, chloramphenicol, ertapenem, 
metronidazole and piperacillin/tazobactam, 95% to clindamycin and ceftriaxone and 
80% to amoxicillin/clavulanic acid (Figure 27). 
 
Figure 27. Susceptibility testing results of the Peptostreptococcus group 
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Intermediate sensitivity was observed with this species. 5% of the isolates were 
intermediately sensitive to amoxicillin/clavulanic acid and ceftriaxone (Figure 28). 
 
 
 
 
 93
Figure 28. Distribution of susceptibility of the Peptostreptococcus group to 
amoxicillin/clavulanic acid 
 
 
 
 
A total number of 25 strains of Prevotella species were identified as: Prevotella 
melaninogenicus (15), Prevotella buccae (3), Prevotella disiens (1), Prevotella bivia 
(4), and Prevotella oralis (2). All isolates exhibit 100% susceptibility to 
chloramphenicol and ertapenem, 84% to metronidazole and 96% to clindamycin, 
amoxicillin/clavulanic acid and cefoxitin (Figure 29). 
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Figure 29. Susceptibility testing results of the Prevotella group. 
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Once more intermediate sensitivity was demonstrated in this group, 36% of the 25 
strains of Prevotella species were intermediately susceptible to ceftriaxone and 4% 
to metronidazole (Figure 30). 
 
Figure 30. Distribution of susceptibility of the Prevotella group with ceftriaxone 
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6.0 Discussion  
Generally, chloramphenicol, piperacillin/tazobactam, ertapenem and 
amoxicillin/clavulanate demonstrated the highest activity to anaerobic isolates, such as 
100%, 99.4%, 97.2% and 96.7%, respectively. Among the 180 tested anaerobes a total of 
8.9% resistance has been observed to metronidazole and 18.3% to clindamycin.  
From present study Bacteroides fragilis was isolated from 81 (45%) clinically significant 
specimens, followed by Clostridium perfringens 23 (13%), Peptostreptococcus anaerobius 
15 (8%) and Prevotella melaniniogenicus 15 (8%). 
Susceptibility profiles of Bacteroides fragilis from our study to few antimicrobial agents 
were similar to study done in Brazil. The resistance rates reported in Brazil were for 
cefoxitin (12%), cefotaxime (15.1%), chloramphenicol (1%), clindamycin (18.2%) and 
tetracycline (75.7%). Sixteen isolates showed reduced susceptibility to metronidazole 
(MIC 2-4 µg/ml) [81] compared to the present study were resistance to cefoxitin was 
(8.6%) and intermediate susceptibility (13.6%), clindamycin (14.8%) with intermediate 
susceptibility of (4.9%), metronidazole (12.3%) with an intermediate susceptibility of 
(2.5%) and no resistance to chloramphenicol and amoxicillin/clavulanate. In this study 
MIC50 was 0.5 µg/ml and MIC90 was 128 µg/ml for metronidaziole.  
Bandoh et al and Betriu et al [10; 11] have reported clindamycin resistance rates as high as 
33% for B. fragilis, 36% for B. thetaiotamicron, 49% for B. distasonis, and 46% for B. 
caccae. Also Oteo et al [78] reported an overall rate of resistance to clindamycin of 49% 
for the B. fragilis group. In this study, 18.7% of the Bacteroides group isolates were 
resistant to clindamycin; however 6% were intermediately susceptible. 
C. perfringens exhibited no resistance to penicillin and metronidazole 
The single isolate of Clostridium fallax, Clostridium sordelli and one isolate of 
Clostridium septicum were all sensitive to each of the tested antimicrobials. The other 
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isolate of Clostridium septicum showed high level of resistance to metronidazole with MIC 
256µg/ml. However the only isolate of Clostridium paraputrificum isolated and tested in 
this study was resistant to clindamycin and cefoxitin with MIC 256 µg/ml. 
 
Koch et al [60] from Cape Town, South Africa demonstrated 4% of the Clostridium 
perfringens (26 isolates in total) resistant to benzylpenicillin and clindamycin, but sensitive 
to the other antibiotics (cefoxitin, metronidazole, chloramphenicol and co-amoxiclavulanic 
acid). Five Clostridium spp. were sensitive to all antibiotics tested. In comparison to 
current study, from the 23 strains of C. perfringens tested all were fully sensitive to 
penicillin but 4.3% were resistant to clindamycin and 8.7% were intermediately 
susceptible.  
P. melaninogenicus was resistant to penicillin in 60% and 6.7% to metronidazole. From 
two isolates of Veillonella parvula tested, one was sensitive to cefoxitin, ceftriaxone, 
chloramphenicol, metronidazole, and ertapenem and intermediately sensitive to 
amoxicillin/clavulanic acid, while the other one was only resistant to penicillin and 
intermediately sensitive to ceftriaxone. 
Thre isolates of Eubacterium lentum were tested, two of which were sensitive to all the 
antimicrobials as the other was resistant to cefoxitin and clindamycin and intermediately 
sensitive to ceftriaxone. 
Fusobacterium species and Fusobacterium nucleatum were sensitive to all the tested 
antimicrobial agents; Fusobacterium varium was highly resistant to ceftriaxone; and 
Fusobacterium mortiferum demonstrated resistance to penicillin, clindamycin and 
ceftriaxone. 
The particular strain of lactobacillus that was tested was only resistant to metronidazole 
MIC 256 µg/ml. 
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In the present study, 97.2% of all isolated anaerobes were susceptible to ertapenem except 
1.7% with intermediate sensitivity. Similary Goldstein et al [45] demonstrated that 
ertapenem was uniformly active against 1001 isolates including all Bacteroides fragilis 
group species isolates, with the exception of 12 (20%) strains of 61 Bilophila wadsworthia, 
3 strains of lactobacilli, and 1 isolate of Acidaminococcus fermentans. 
 
A total of 370 clinical isolates of anaerobic bacteria from patients at a university hospital 
were investigated, in a prospective study, over a time period of 6 months by Pfister [82], 
with the exception of one strain of Fusobacterium varium all other anaerobic isolates were 
sensitive to ertapenem.  In addition, one isolate of B. fragilis exhibited resistance to 
ertapenem (MIC 32µg/ml) while four other isolates demonstrated intermediate sensitivity. 
In the study performed by Koch [60], 20 strains of Peptostreptococcus anaerobius were 
tested and 10% were resistant to benzylpenicillin, cefoxitin and metronidazole; from others 
17 Peptostreptococcus spp 12% showed resistance to benzylpenicillin and 6% to 
metronidazole and clindamycin whereas in the present study from the 20 strains of 
peptostreptococci 35% was resistant to penicillin and a 5% to clindamycin and no 
resistance to metronidazole.  
 
 Appelbaum and Chatterton [9] performed a similar study in Durban, South Africa, on 265 
anaerobic bacteria from clinical isolates. Their results indicated low levels of resistance to 
antimicrobial agents that cover anaerobic organisms such as penicillin G, chloramphenicol, 
clindamycin, and metronidazole. In comparison to our results chloramphenicol remains 
100% susceptible but clindamycin exhibited a susceptibility of 81.7%, metronidazole 
89.4% and penicillin 33.3%, indicating increasing trends in resistance.  
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7.0 Conclusions 
 
For first time the present study provides baseline data on antibiotic susceptibility patterns 
of anaerobic isolates from patients at Charlotte Maxeke Johannesburg Academic Hospital, 
and should be used as background information for future studies. 
Our study demonstrates a change in the susceptibility patterns of anaerobic organisms and 
an increased resistance to metronidazole particularly to the B. fragilis group.  Furthermore 
the high rates of intermediate susceptibility to other antimicrobial agents indicate need for 
periodic active surveillance to identify and record these emerging trends. 
From a clinical perspective, our susceptibility results may guide clinicians to use 
antimicrobial agents such as amoxicillin-clavulanate or piperacillin-tazobactam and 
ertapenem for empirical treatment of mixed infections particularly those associated with 
anaerobic organisms.  
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